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Summary
The work outlined in this thesis was conducted between 
October 1984 and September 1987 and is primarily concerned 
with the synthesis of 7- and 8-substituted ellipticine 
derivatives.
The starting material for the synthesis of 6-H- 
7-C3-(N,N-d iethylami no)propyl 3-1,4-d imethy1-9-methoxypyrido- 
C4,3-b3carbazole was 9-<N)-ally1-1,4-dimethy1-6-methoxy- 
carbazole which was rearranged to the 8-(C)-allyl isomer and 
the side chain then degraded to give 8-formy1-1p4-dimethy1- 
6-methoxycarbazole. The N,N-diethylaminopropyl unit was 
introduced via an Emmons Horner reaction followed by 
reduction while ring D of the pyridocarbazole was built up 
following a modified Cranwel1-Saxton approach.
The nature of the rearrangement reactions of both 
N-allylcarbazoles and also of ally1oxycarbazole have been 
investigated. From 6-allyloxycarbazole, 7- and 5-allyl- 
carbazoles are formed? these compounds could form the 
starting materials for ellipticines bearing solubilising 
side chain groups at C-8 and C-10 respectively.
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Section I
Syntheses And Biogeneses 
Of Ellipticine And Its Derivatives
1.1 Background
The alkaloid ellipticine JL (6H-5,11-dimethy1pyrido- 
C4,3-blcarbazole) was first isolated in 1959 from the 
leaves of Ochrosia el 1iptica Labill. (family Apocynaceae), a 
plant harvested at a United States Department of Agriculture 
Plant Introduction Station in Florida (1) (It grows wild in 
Oceania.)
Later, in an examination of Australian plants for 
substances with antitumour activity, scientists at the 
Cancer Chemotherapy National Service Centre of National 
Institutes of Health, in the U.S.A. obtained extracts from 
two botanically related species, Ochrosi a moorei F. Muell. 
and Excavat i a coccinea (Tejs. Sc Bin.) Mgf. (family 
Apocynaceae). From these extracts, several alkaloids, in 
particular, ellipticine JL and 9-methoxyel1ipticine 2  were 
isolated. These alkaloids were shown to account for the 
activity of the extracts against the experimental tumours 
Sarcoma 180, Adenocarcinoma 755, and Lymphoid leukaemia 




carcinoma of the nasopharynx carried in cell culture (2).
Since then the isolation of ellipticine and related 
compounds from various other species of the genera 
Asp idosperma. T abernaemontana and Strvchnos of the 
Apocynaceae have also been reported (3-11).
In 1959, Woodward et. a_l.» published the first total 
synthesis of ellipticine thus confirming its tetracyclic 
structure (12). Now almost three decades have elapsed, yet 
work on this family of compounds continues apace and many 
new facets of the biology of the ellipticines are being 
unrave lied j— muo h—r esurrts~acrcirlmu 1 ated. Much of t he ear 1 y 
synthetic work has been summarised in reviews and other 
publications (13-16) and as might be expected for compounds 
with interesting pharmacology, many workers have sought, and 
seek, to provide short versatile preparative routes to them. 
The biogenesis of the ellipticines is also of interest (17)
u,
not least because there is an unusAal number of and 
disposition of carbon atoms between C-3 of the indole unit
and the pyridine nitrogen. The normal precursor of indole
P
alkaloids is tryAtophan with two carbon atoms in the side 
chai n.
As well as many derivatives of ellipticine itself, 
some analogues, e.g. ZS-ZP', have also been synthesized 
(18-20) (Figure 1). These will not be discussed here where 
the focus of attention will be pyridot4,3-bIcarbazo1e 
chemistry and biochemistry.
r 5 r 2
JL R1=R2=Me R :
y -r 6=x =n W=
33 as ± , except: R^
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1.2 Biogeneses of ellipticine
The study of the biological origin of an alkaloid is
both fascinating and challenging in its own right. In an age
when biotechnology is growing fast, ideas of employing
living matter as production lines to generate useful 
chemical products are being constantly put forward. This 
also demands a sufficient knowledge of the biosynthesis of 
these products. A common difficulty associated with the 
determination of biogenetic pathways in higher plants is the 
lack of supporting experimental evidence. There is no
exception in the case of ellipticine (17,21).
Ellipticine JL and its natural isomer olivacine 3  
usually co-occur with uleine JLO (22) and apparicine S? 
(23). It is therefore presumed that these alkaloids have the 
same progenitor (16) and Wenkert in 1962 and Potier et al. 
in 1973 have each put forward proposals to account for their 
biogenesis (24,25).
Potier*s hypothesis, based upon a biological version 
of the Palonovski reaction is the most recent (26-29); he 
envisages that stemmadenine-N-oxide Q  is the key 
intermediate. This is presumed to undergo a modified 
Polonovski type reaction to give a number of indolenium 
products which variously cyclise to the four congeners 


















F i qure 2
-5-
In an alternative proposal, Wenkert (24) also 
postulates a common precursor, A 5, but this is derived 
from an anthranilic acid derivative A 3  and a 
seco-prephenateforma1dehyde (SPF) unit A A or more likely, 
secologanine A 2 .  Cyclisation of this precursor first to an 
indole A ^  and then to an iminium species A 5  might 
ultimately afford the same series of alkaloids (Figure 3) 
although it should be noted that apparicine is not
i nc1uded.
As stated earlier, tryptophan is considered to be the
usual source of the indole ring of most alkaloids and
naturally there has been some controversy over which, if 
either, scheme is correct. Sadly despite some effort, the
biosynthesis of ellipticine remains in doubt, although there
P
are claims that a very weak incorporation of trytophan into
A
stemmadenine and uleine has been observed. The incorporation 
of labelled substrates into higher plants is notoriously 
difficult so this result is not surprising, and no new work 
in this area has been presented to resolve the problem.
1.3 Syntheses of ellipticine and its derivatives
Since 1959, much has been committed to the exploration 
of general and efficient synthetic routes to ellipticine and 
its derivatives. As a result, a large number of routes have 
been developed. These have been reviewed by Sainsbury (13), 
Shannon e_t a_l_. (14), Gribble (15) and Potier et. aj_. (16).
- 6 -
Hence, only a selection of the routes will be presented 
here. Indeed it is debatable whether effort should still be 
directed towards the synthesis of ellipticine itself since a 
number of convenient routes are now available.
11 SPF unit
12 Secologanine
H O  H 2NC H3
1.101 
2. 11 o rl2
Figure 3
It has been shown that 9-hydroxye 1 1 i pt i c i ne J. «£» , a 
major metabolite of ellipticine in the rat (30), is forty 
times more active than ellipticine against leukaemia L1210 
implanted in mice (31-32) and recently, other more active 
ellipticine derivatives have also been reported (33). As a 
result, current synthetic interests have shifted towards the 
construction of derivatives that contain substituents more 
likely to impart even greater activity or to improve 
solubility in aqueous media, and hence ease of 
administration to the patient.
The most popular method of classification of the 
various synthetic strategies was introduced by Sainsbury 
(13) who divided the approaches into three types: B, C and D 
based upon the last ring to be constructed in the synthesis. 
A fourth type, i.e. B+C was later added by Potier et. a_L» to 
include a new synthetic method in which two rings, B and C, 
are simultaneously formed as the last step (16).
-8-
1.3.1 B Type syntheses
Only a few routes fall into this catagory yet this is 
one of the first avenues to be explored. For example, 
Woodward and Stillwell (34) designed a synthesis of 
ellipticine that required a Fischer indole ring forming 
reaction as the key step (Figure 4). Unproductive in their 









Another related strategy was considered by Bisagni 
et a 1. (19,35-37) which they regularly employed tor the
syntheses of 9-aza-ana 1 ogues of ellipticine, <£>. Perhaps the 
best of these approaches is that of Miller and co-workers 
(38) who have described syntheses of both ellipticine A 
and 9-methoxyel 1 ipticine S  (Figure 5). In this work, 
substituted n i t roan i 1 i nes ATT* are coupled with 6-bromo- 
5,8-dimethy1isoquinoline A S  under Goldberg’s condition to 
furnish the corresponding diary1 amines A *P . Reduction of 
the nitro group in these products with hydrazine hydrate/ 
Raney-Ni, followed by diazotisation gives the benzotriazo1es 
S O  which are pyrolysed at 500 °C to yield the required 
tetracycles (39). The key starting intermediate A S  is not 










Workers in this laboratory have shown that Miller’s 
work is very reliable, but the labour required in the 
preparation of this isoquinoline JL £3 severely limits the 
attraction of this synthesis, to say nothing of the need for 
a very high temperature in the pyrolysis step. The latter 
factor tending to rule out this route for the synthesis of 
more complex and labile analogues.
Previously, Miller ejt a_l_- had reported another 
approach which, unfortunately gave the undesired structural 
isomer as the major product (40). In this route, the azido 
compound 2 X  was chosen as the nitrene precursor and upon 
heating to 180-200°C, it gave two isomers: ellipticine X
and the indolenine 2 2  in a ratio of 1:3 (Figure 6).
This result contrasts with the observation that when 
the biphenyl azide 2Z3 is thermolyzed, 1,4-dimethyl-
carbazole 2*3- is the only product isolated. Indeed no 
3,3-di-substituted indolenine was detected in the n.m.r.
spectrum of the crude reaction mixture. It is obvious that 
the pyridine nitrogen atom has a major influence on the 
electron availability within Miller’s assumed intermediate.
1.3.2 C Type syntheses
This is the largest class of all (13-16), not
surprisingly since the starting materials are preformed
indoles and pyridines. Woodward was the first to see the 
attractiveness of using indole 2 5  and 3-acetylpyr id i ne
-11-
12 <£> as starting materials (12) in his synthesis (Figure 7). 
However, the last two of the three steps involved did not 
prove satisfactory and the overall yield in the Harvard 
synthesis was less than 2%. The synthesis has never been 
used subsequently, but its simplicity has served as an 






An interesting development has emerged from the 
laboratory of Snieckus (41) who has reported a route which 
employs a so-called "tandem-directed metalation" sequence. 
Several N-protected 3-formylindoles 72 7^ were allowed to 
react with lithiated N ,N-diethy1isonicotinamide 2  £3 to
yield the corresponding i ndol opyr i dobenzoqui nones 2  9 - 3  1  . 
The yields are found to be inversely proportional to the 
ease of removal of the protective group R. The quinones
were then transformed individually in a three-step sequence,
without purification of intermediates, into the appropriate 
pyr i docarbazo 1 es 3  Z2. , 3 3  and JL (Figure 8). The quinones
2 <5>- 3 ±  are handy precursors of simple ellipticines. Other 
workers have also recognised this fact and devised
alternative routes to them (42,43).
Figure 7
-13-




1 HI (47%) 
2AcOH/HC(
R % Yield from
Figure 8
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Gribble et a 1 . have also reported a related 
methodology for the syntheses of some 5-substituted
ellipticines (44,45). Thus, by the reaction of
2- 1 i t h i o- 1 -pheny 1 su 1 phony 1 i ndo 1 e 3 5  with c i nc homer on i c
anhydride 3  <£> at -100°C, these workers have obtained the
ketolactam 3 S  which then yielded a d i as t er eomer i c mixture 
of diols 3 S *  (R.j=R2=Me) on treatment with excess
me t hy 1 1 i t h i u m . These diols were converted to ellipticine JL 
by the action of sodium borohydride, thereby affording a 54% 








40 Ri = <^y
R2=CHa
P= SOz
R = Hi OMe
Figure 9
-15-
Repetition of the sequence with 5-methoxyindo1e qave 
9-methoxyel1ipt icine 32 in 47% overall yield.
In addition, it was also shown that the synthesis 
allows the manipulation of the substitution pattern at C-5
and C-ll because the carbonyl groups of the quinones 3£3
exhibit different reactivities toward alkyl lithiums. This 
is due to the fact that one of them is less amidic then the 
other. Exploiting this observation, Gribble and his 
colleagues (45) have reported a total synthesis of
5-oxoel 1 i pt ic i ne <3- JL through oxidative cleavage of
5-vi ny lei 1 ipt ic i ne *3-0. The formyl compound ^  JL has also 
been recently synthesized by Archer et. ai.. by another 
approach (46) .
Many workers have considered the construction of ring 
C via a Diels-Alder eye 1oaddition reaction, but all the 
published results indicate a lack of regioselectivity. 
Nonetheless, in Moody’s synthesis (47), the low yield of 
ellipticine obtained is compensated by the brevity of the 
route (Figure 10). Thus 3-(3,3-dimethy1triazen-1-y1)- 
pyridine-4-carboxy1ic acid ^  , a precursor of 3,4-pyridyne 
-^3, was reacted with the diene, 1,4-d imethy lpyrano-
C3,4-bl i ndol -3-one Z2. to give a 50:50 mixture of 
ellipticine and isoe11ipticine 37 in 40% yield.
Similarly, in a related synthesis, Gribble et. aj_. (50) 
reacted pyridyne 3  with 1,3-dimethy1-4-(phenylsulphony1)- 
4H-f uro[3, 4-bI i ndol e <3-5 to give ellipticine JL and iso- 












in CH3CN 1 +




In recent years, attention has been focussed on the 
introduction of more elaborate groups into the C ring in 
order to improve the theraputic index of the el 1ipticines. 
An illustration is provided by the work of Pandit (49). Here 
the exocyclic methylene compound ^ 3 ^  was prepared in seven 
steps from N-methyl i ndol e ^  «£» and subjected to
-17-
N-ch1orosucc i ni mi de, aqueous potass ium hydroxide and thionyl 
chloride. This eventually resulted in the formation of the 
ch1oromethy1e11ipticine & .  Displacement of the chlorine 
atom by various nucleophiles, such as substituted amines and 
carbohydrates, furnished derivatives of 6-methy1 el 1ipticine 
that bear various substituents at the C-ll position, 
^ ^ * - 3 2  (Figure 12). The same workers later commented that 
direct lithiation at the C-ll methyl group of
6-methy lei 1 ipt ic i ne 3 2  was possible using lithium diiso- 
propylamide at -78°C (50). Hydroxymethy1ation of the 
lithiated intermediate with formaldehyde then gives the 
hydroxy derivative S 3 .  Glycosides S ^ - S A  were sub­
sequently prepared by coupling the product with the 
appropriately derivatized sugar using tin tetrachloride as 
catalyst (Figure 13). None of these compounds are ring A 
hydroxylated and Pandit ejt a K  recognising the importance of 
hydroxy group at the C-9 position for anticancer effect, 
sought to develop. an indirect 9-hydroxy1 ation procedure 
(51). In a demonstration of this technique,
6-met hy 1 e 1 1 i pt i c i ne 3 2  was formylated at the C-9 position 
and this product subjected to the conditions of the 
Baeyer-Vi11iger rearrangement with hydrogen peroxide and 
sulphuric acid in methanol. This gave
9-hydroxy-6-methylel 1 ipt icine S Q  in greater than 90% 















2 K O H ^ / i 5 0 ° C








R = OH 77%
49 R = HN*v^ n.OH 70%
50 N K /^ O H fe  60%
51 N K ^ \ c i ) 2  60%
52 86% 






















H20 2 (35% )






However, it has to be noted that the utility of all 
the methodologies developed by Pandit depend greatly on the 
success of replacing the 6-methyl group with other easily 
removable protecting groups. 6-Substituted ellipticines are 
not effective anticancer agents and Pandit, significantly, 
did not claim useful activity for his products. In view of 
this well established fact, it is hard to see why the Dutch 
workers did not protect the indolic nitrogen atom with a 
more easily removable group. It would have also been 
sensible to have had the 9-hydroxyl group, or its equivalent, 
in place early in the synthesis.
At a glance, it seems many of the C type routes can 
easily be extended to the syntheses of ellipticine 
derivatives with various substitutions on the A ring, simply 
by replacing indole with other appropriately substituted 
indoles. However the range of substituted indoles supplied 
commercially is very limited, and some of them can be very 
expensive.
Indeed, syntheses of some substituted indoles are not 
always straightforward (52). The following methodology 
developed by Sainsbury e£ aj_. seems to have solved this 
problem, and it has been used in recent years to synthesize 
a number of ellipticine derivatives with various
substituents on the A ring (53). More recently, an 
application of the same route, has afforded compounds 
6 8 - 6 9  with unusual groups at C-5 (54,55). The entire
route can be divided into two major stages: to the synthesis
-21 -
of pyridylaldehyde <£> O , which is then reacted with an 
ary1hydrazine in the presence of methanolic hydrogen
chloride. Hydrazone formation is immediately followed by 
Fischer indolisation to give the pyridylethy 1 indole «£» 1 in 
ca. 60-80% yield. These products are substituted at the 
pyridine nitrogen atom with an easily cleavable group which 
also facilitates the nucleophilic addition of cyanide ion at
the 4-position of the resulting pyridinium salt <£>2.
Exposure to sunlight is usually sufficient to generate the 
nitrile <£»I3, which react with alkyl lithiums to yield
imines <£>*3-. These are easily hydrolyzed to the 
corresponding ketones by heating with acetic acid, but the 
carbonyl compounds are never isolated, undergoing 
spontaneous ring closure to the ellipticine targets (Figure 
15) .
Regio-control over the indolisation of hydrazines
having two available ortho sites is normally impassible. 
Thus the meta-subst i tuted methoxypheny 1 hydrazone 2 0  yields 
a mixture of the methoxyel 1 ipt ic i nes, 2  1 - 2 2 ,  the former 
predominating (Figure 16). Unfortunately, mixed ellipticines 
are not easily separated one from the other.
1.3.3 D Type syntheses
Synthetic routes of this type are few and have mainly 
been used to synthesize olivacine Z3 and its derivatives 















R2=Me 65 R = 7 -C l
66 7— F
6 7 7—Me
R = H 68 R2 =
69 R2= ^ 3
Figure 15
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Cranwell and Saxton have reported a very efficient 
synthesis of 1, 4-d imethy 1 carbazol e <R=H) from indole
and 2,5-hexadione 2 and converted it into ellipticine JL 
(58). Over the years, their work has been adopted and 
improved on so that a number of simple ellipticine 
derivatives have been produced in bulk and used for
pharmacological evaluation (2). There is no doubt that the 
Cranwell and Saxton route is the most popular ellipticine 
synthesis of all, yet is one of the oldest. Two problems 
attend it, however* originally the carbazole was
C-formylated and converted into the corresponding 
imines 2  !✓* . Direct cyclisation of these products was very 
inefficient so it was necessary to reduce them to the 
related amines 2 S ,  ring close and reoxidise the 
dihydroe11ipticines so formed. This sequence added 
undesirable length to the route. Secondly where the
carbazole contains electron donating groups, these may
-24-
affect the site of formylation. In order to address the
first problem, Shannon e^ a_l_. (59) have taken the
amines Z? £3 and reacted them with 4-to 1uenesu1 phony 1
chloride. When the N-tosyl derivatives Z? are heated with
acid, ring closure is followed by elimination of
4-to1uenesu1phinic acid to give the ellipticines S  1 
directly (Figure 17).
Me









In this way the handling problems associated with 
1,2-dihydroisoquino1ine derivatives are avoided, this is 
important since these compounds tend to disproportionate and 
also to react with oxygen giving isocarbostyri1s.
The second problem have been tackled by Bisagni et al. 
(60) and is employed to prepare 1-amino substituted 
ellipticines (Figure 18). For example, the dihydro- 
carbazole was prepared in five steps (11% overall
yield) from 4-methoxybenzenediazoniurn chloride and 4-methyl- 
1-morphol inocyclohexene and oxidised to the carbazole £ 3 5  
using manganese dioxide. The exact location of the formyl 
group is now pre-arranged so that the remaining annulation 
reactions can only afford an ellipticine. This is, however, 
hardly a practical approach since the construction of the 
dihydrocarbazole is by no means a trivial procedure. But in 
this case, Bisagni wished to functionalise the C-l site of 
the targeted tetracycle and the isocarbostyri 1 £3«£> seemed 
to be a desired intermediate. Unfortunately, treatment of 
this compound with phosphorus oxychloride gave the
1-ch 1 oroel 1 i p t i c i ne 8 7  in only 25% yield. Whereas a 73% 
yield was obtained in the same reaction in the olivacine 
series where a methyl group is not present at the C-ll site, 
thus presenting no steric problem for the reaction. The side 
chain was subsequently introduced by condensing the 
ch1oroe11ipticine with 3-NT,N*-diethy1 aminopropyl amine to 
afford the product S  C3 .






















2.3%  ove ra ll yield
Figure 18
-27-
1.3.4 B+C Type syntheses
Ghosez ejt a_l_. (61) have reported the only example of
this type of ellipticine synthesis (Figure 19). The acid 
chloride and the aniline in the presence of
triethylamine yielded 75% of crude anilide S?JL. To avoid 
any loss of material, the crude anilide was used directly to 
generate the vi ny 1 ketenimine which when heated,
underwent intramolecular eye 1oaddition to yield the 
tetrahydropyridocarbazole ^ 3  which was reduced to the 
t etrahydroel 1 i pt i c i ne The latter compound has
previously been converted to ellipticine in low yield, by 
other workers (62). Although this route is highly 
convergent, its applicability has yet to be proven.
-28-
















Biological And Pharmacological 
Properties Of Ellipticine And Its Derivatives
2.1 Antitumour activity of ellipticine and its 
der i vat i ves
The majority of the thirty or so currently clinically 
useful anti-neop1astic drugs are believed to interfere with 
aspects of DNA function (63-66). Those compounds that 
directly interact with DNA constitute an increasingly 
important group of such drugs, and are exemplified by 
cis-platinum, amsacrine, bleomycin and doxorubicin, as well 
as the more traditional alkylating agents. Interference with 
the processes of DNA transcription, replication, RNA 
synthesis and topoisomerase action, have been variously 
noted for these agents; the precise mechanisms whereby they 
have a selectivity for tumour cells remain unclear, although 
their differential effect on rapidly-proliferating cells is 
an important factor.
Ellipticine is a natural antitumour antibiotic which 
is being tried and further developed for human anticancer 
treatment. There is a great need for new DNA-reactive 
anticancer drugs because of the narrow spectrum of activity 
and narrow theraputic index of current drugs, many of which 
fall into the six rather artificial categories:
a. alkylating agents and analogues




e. Vinca alkaloids and analogues
f. biological reponse modifiers
Reduction of toxic side effects and an improvement of 
target specificity are the two important goals in drug 
research. Relating to the former aspect, trials with 
ellipticines in animals have shown minimal toxicity with 
useful antitumour activity. Trials in man have confirmed 
that the ellipticines are not myelotoxic, but unfortunately, 
they do have other dose-limiting toxic effects (67).
Considerable interests in the medicinal value of 
6H-pyridoC4,3-bIcarbazoles began after the disclosure of the 
useful inhibitory properties of ellipticine and 
9-methoxyel1ipticine against a variety of cancerous tumours 
(68). Thus, ellipticine and its derivatives have been shown 
to inhibit the growth of various experimental tumours, for 
example the Walker 180 sarcoma, Adenocarcinoma-755, L-1210
leukaemia and myeloblastic leukaemia (2,69-71). Since then, 
it has been established that some skeletal modifications of 
ellipticine diminish its antitumour effect (2,72-75). For 
instance, the presence of methyl groups at the C-5 and C-ll 
positions are necessary for the manifestation of cytotoxic 
effect on mice leukaemic L1210 cells (33,75). The 
quaternisation of the pyridinium nitrogen of
9-hydroxye11ipticine has furnished a highly active compound, 
9-hydroxy-N-2-methy1e 11ipticinium acetate 5  (76) which
has recently been used, for example in the treatment of
-31 -
osteolytic metastases of human breast cancers (77-78). 
9-Hydroxye11ipticine is forty times more active than 
ellipticine against murine L-1210 leukaemia whilst the 
corresponding 7-substituted isomer is six times less active 
than ellipticine (79). It is interesting to note that 
8, 9-methyl ened i oxy- *P <£» and 8, 9-d i met hoxye 1 1 i pt i c i ne "Z? 
(Figure 20) exhibit no antitumour activity against the solid 
form of Walker sarcoma 180 and that of Ehrlich carcinoma in 
mice. In addition, various esters S?©  of 9-hydroxy- 
ellipticine show either weak or no activity (68).
96 R ^ s O C H j O  
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A comparative study of the mutagenic and cytotoxic 
activities of various ellipticine derivatives has been made 
by Paoletti e_t aj_. <79) using the Chinese hamster ovary cell 
hypoxanth i ne-guan i ne phosphoribosy1 transferase assay <CHO/
H6PRT assay) and on tests with Salmonella. They have shown
that ellipticine, 9-methoxyel1ipticine, 9-hydroxy-
ellipticine, 9-aminoe11ipticine, 2-methy1-9-hydroxy-
el 1 ipticinium acetate are all cytotoxic and mutagenic, 
although 9-aminoel1ipticine has only marginal mutagenicity. 
They have also found that the latter compound intercalates 
only weakly and may instead exert its mutagenic activity 
primarily (or exclusively) by forming a covalent adduct with 
DNA. On the other hand, ellipticine, 9-methoxyel1ipticine, 
9-hydroxyel1ipticine appear to cause frame-shift mutations 
by both intercalation and covalent binding with DNA.
Paoletti concludes that:
a. the various ellipticines do not all interact with 
identical DNA sequences in the various strains of 
Salmonel1 a.
b. only a small portion of the frame-shift mutagenicity 
shown by most ellipticines is due to simple 
intercalation.
c. there is no obvious correlation between mutagenicity 
i n v i t ro and antitumour activity j_n. v i vo.
In animals, it is likely that most of the hydroxylated
-33-
pyridoI4,3-bIcarbazo1e administered is excreted in the urine 
as conjugates (80). In cell culture, however, it has been 
shown that 9-hydroxye11ipticine is much more cytotoxic and 
mutagenic than ellipticine itself, and has the highest 
affinity for DNA.
Paoletti has also shown that the antitumour activity 
exhibited by 2-methy1-9-hydroxye11ipticinium acetate when 
tested against L1210 leukeamia implanted in mice is only 
second to that exhibited by ellipticine; whilst its cy­
totoxicity in L-1210 leukaemia cells is lower than that of 
9-hydroxyel1ipticine (81). Subsequently, this compound has 
been developed by the French company S.N.O.F.I. as a soluble 
form of the anticancer agent.
It should also be noted that the 9-aminoel1ipticine 
used in Paoletti*s work originated from the laboratory in 
Bath and was synthesized by Sainsbury and Webb in 1973. 
Regretably, this fact has never been acknowledged by the 
French workers.
Paoletti et. al_. have also found that ellipticine and 
its 9-substituted derivatives bind to the heme iron atom of 
cytochrome P-450 and thus inhibit microsomal monooxygenase 
(75). Consequently, 9-hydroxyel1ipticine has been shown to 
be a potent inhibitor of a wide variety of mutagens that 
require metabolic activaton, suggesting its usefullness in 
treatment for accidental exposure to chemical carcinogens 
(82) .
Very recently, Archer et. aj_. (33) described the
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biological activities of three ellipticine derivatives, 
^ ^ - ± 0 1 ,  against murine P388 lymphocytic leukaemia in 
mice (Figure 20). Results showed that the 5-hydroxmethy1 
derivative and ellipticine JL were about equally potent
whilst the corresponding carbamate JL O O  and ester 1 O  1
were both significantly more cytotoxic and antitumour 
active, particularly the carbamate.
The pharmacological properties of some pyridocarbazole 
analogues of ellipticine have also been reported and should
be briefly mentioned. Bisagni et. al_. have synthesized a
series of ellipticine and olivacine derivatives with various 
lipophilic and hydrophilic side chainsattached at the C-l 
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When tested on the L-1210 leukaemia system, the 
diamine JL O  22 and JL 0 13 were said to exhibit cytotoxic and 
antitumour properties. In addition, demet hy 1 at i on of the 
latter compound at C-9 served to increase its cytotoxic, but 
did not change its antitumour activity. Interestingly, the 
presence of the various side chains at the C-l position 
(except for 3-N*,Nf-diethy1 aminopropy1 ami no) did not improve 
their anticancer effect compared to ellipticine and 
sometimes led to inactive compounds. In the case of the 
C - H  derivative ±0*3-, it was found to have some 
cytotoxicity but weak antitumour activity.
Roques et. aj_. (85-87) have investigated the 
relationship between DNA binding affinity and the 
cytotoxicity of a number of the angular pyridocarbazoles 
X 0 5 - 1  CD<£» where the pyridine atom is located at various 
positions in ring D (Figure 22). Although the binding 
affinities of these compounds are comparable to those of the 
14,3-bl series, their cytotoxicty measured against L-1210 
leukaemia cells .in. vitro differs significantly. The 
cytotoxicity of the first series was low compared to 
ellipticine whilst that of the second group was much lower. 
Interestingly, when the "dimers" (these are products of two 
identical monomers linked together by a spacer at the 
pyridine nitrogen site) of the ellipticine type JLO'IT' and 
of the angular isomers l O S  were compared, the former was 
said to have insignificant antitumour activity, but the 
latter were claimed to be highly active. It was also painted
- 3 6 -
out that a rigid spacer, e.g. of the bipyridyl type was 
necessary in order to produce active compounds.
The above observations clearly suggest that any direct 
comparison between the activities of ellipticines and their 




2.2 Mechanism of action of ellipticines
The mechanism of action of ellipticine jji v i vo and its 
derivatives is still not well understood, despite the fact 
that a great deal of work has been carried out on the 
problem (16). In recent years, some progress has been made, 
however, and various new hypotheses have been proposed. 
Considerable pharmacological evidence supports the view that 
DNA is a critical cell target for ellipticine, but still 
leaves the following questions to be answered:
1. Does the drug react with a replicative enzyme or
protein, DNA polymerase, RNA polymerase, topoisomerase 
(e.g, DNA gyrase), or helix destabilizing protein or 
directly with the nucleic acid template itself?
2. Does the drug require specific activation, reduction,
oxidation, or protonation, and if so at what 
positions?
3. Does it require a co-factor such as metal ions or an
oxygen molecule?
It is now generally accepted that the pharmacological 
activity of ellipticine can be interpreted by more than one 
mode of interaction. These are described in the following
-38-
sect ions.
2.2.1 DNA affinity of ellipticine
It is believed that the antitumour activity of 
ellipticine and its derivatives is in part related to their 
high DNA binding affinity (88). Many of them bind to doubly 
stranded DNA with an affinity coefficient of 10-  ^ to 10”  ^ M 
(88). However, no correlation between their antitumour 
activity and DNA binding affinity has been established. 
There are many derivatives having nearly the same DNA 
binding constants which have been found to be either less or 
not active when compared to ellipticine itself (16,85). More 
than one form of binding relationship is possible. 
Intercalative and covalent binding are the two major 
contenders and these are discussed in separate sections 
below, but there could also be reversible non-intercalative 
interactions on the outside grooves of DNA (89).
The efficiency of intercalative binding can vary 
depending on the presence of additional functional groups; 
as stated earlier, it has been found that the addition of an 
amino, hydroxy or methoxy group at C-9 leads to a ten-fold 
increase in the DNA binding constant (88), presumably due to 
hydrogen bonding with two base pairs. It has been suggested 
that the hydroxy group of 9-hydroxyel1ipticine can also 
interact with the phosphate sugar backbone through hydrogen 
bonding leading to a generalised affinity between the two
-39-
molecules rather than a site specific one (85).
2.2.2 Intercalative binding of ellipticine to DNA
A wide variety of polycyclic molecules are known to 
bind to DNA by intercalation (90). Some of these, including 
actinomycin (91) and daunomycin (92-93), have essential side 
chains whereas others, including proflavin and ethidium do 
not. These latter molecules may be considered to be "simple" 
intercalating agents and are distingushed by a tendency for 
lower binding strengths, faster kinetics of reaction and 
dissociation (94), and less specificity for binding to 
helical DNA. The two groups differ in their effects on the 
synthesis and processing of RNA in L1210 cells. Ellipticine 
was found to resemble the simple intercalators proflavin and 
ethidium in this regard (95).
Waring et. al_- have reported that ellipticine increased 
the viscosity and decreased the sedimentation coefficient of 
native calfthymus DNA (96). Waring also established that the 
plane of the ellipticine ring system is orientated parallel 
to the plane of the bases of the DNA. Experiments with 
circular DNA showed that the binding of ellipticine results 
in a local unwinding of the double helix as required by the 
intercalation hypothesis. This suggestion of an 
intercalative mechanism of binding was further supported by
i
H n.m.r. studies (97) and a X-ray analysis on a 
co-crystal 1ized mixture of ellipticine and 5-iodo-
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cytidy1y 1 -(3 *-5*)-guanosine (98). The crysta11ographic 
studies also reveal that the size and shape of the 
6H-pyridoC4,3,bIcarbazo1e ring lead to an almost perfect 
overlapping of the aromatic ring with that of a DNA base 
pair, an ideal situation for intercalative binding. 
Anticancer activity and the cytotoxicity of intercalative 
agents generally are associated with interference in at 
least some aspects of transcriptional, and replicative 
processes, as well as with gross DNA damage and consequent 
misrepair (99-100). However, in practice, it is not certain 
as to what extent the antitumour activity can be accounted 
for by the intercalative interaction.
Waring et. a_K have suggested that the basicity of 
ellipticine may have an important bearing on its action on 
cells (96). They noted that when bound to DNA, ellipticine 
may be in its cationic form, the positive charge being 
favored by the negative charge of the macromolecule. Thus, 
the extent of binding to DNA may depend on intracellular pH 
(96). There is some evidence to suggest that cancerous and 
normal cells have different pH, but this is not proven 
(101).
2.2.3 Covalent binding of ellipticine to DNA, RNA, 
protein and amino acid
Paoletti et. al_. (102) have put forward the view that, 
i n v i vo. a biotransformation occurs (Figure 23). This states
-41 -
that 9-hydroxyel1ipticine and the corresponding
e 11ipticiniurn salt S* S  undergo two stepwise single electron 
oxidations in the presence o-f peroxidase to give the phenoxy 












The latter is strongly e1ectrophi1ic and therefore 
would be expected to covalently bind to biomolecules, such 
as proteins and nucleic acids. The imi noqui none JL JL O  has 
been made j_n vitro and under chemical or biochemical 
conditions, undergoes addition reactions with various 
compounds such as amino acids (103), ribo-nuc1eosides and 
nucleotides (104-107). Based on these findings, Potier 
et al. propose that the antitumour activity of this class of 
compound could also be explained on the basis of alkylation 
at the terminal end of t-RNA to stop the formation of 
aminoacyl t-RNA, and at the end of poly-A-tail of the m-RNA 
or the "cap- that is present at the 5*-end of m-RNA. Any of 
these events might thus inhibit the biosynthesis of
proteins. Recently, Dugue e£. aj.- have discovered that
incubation of 9-hydroxy-2-methylei 1 ipticinium salt ^ 5  with 
L1210 murine leukaemia cells at 37 °C for eight hours results 
in covalent binding of the drug to both DNA and RNA, but not 
to proteins (108).
However, despite all the above findings, the validity 
of the various hypotheses ha$ recently been challenged by 
Archer et. al_- (33) . He has shown that the desmethyl 
9-hydroxypyridocarbazole 1 1 JL is inactive against murine 
P388 lymphocytic leukaemia. The absence of the methyl groups 
does not, however, prevent oxidation to an iminoquninone 
which will then react with an amino acid to give JL JL 2 ,  so
Archer concludes this intermediate 1 JL O  is not the key to
activity and alternatively, he proposes that ellipticine is,
-43-
as before, transformed to the 9-hydroxy derivative 1 <£>
(Figure 24). This species, in turn, is enzymically converted 
first into the hydroxymethy 1 compound JL JL 3  , which is then
further transformed to 1 ± . The latter derivative now
prosesses a good leaving group, and functions as an
alkylating agent for macrcmo1 ecu 1e such as DNA etc. to give
products of the general form JL JL S  . This theory is
supported by the much enchanced antitumour activity of the
carbamate as compared to ellipticine and the










2.2.4 Single DNA strand breaks by ellipticine
Pommier et. a_l_. has demonstrated that when 
9-hydroxyel1ipticine is incubated with L1210 cells at 37°C 
tor one hour, single and double strand DNA breaks occur in a 
reversible manner (109). Similarly, Dugue et. aj_. suggested 
that both DNA strand breaks and covalent binding may be 
responsible for the cytotoxicity of ellipticine (108). Ross 
has pointed out that ellipticine causes a higher frequency 
of DNA strand breaks than does adriamycin, yet it is far 
less cytotoxic. He suggests that el 1ipticine-induced breaks 
are rapidly repaired when the drug is removed from the 
surrounding medium whereas adriamycin-induced breaks are 
retained much longer (110).
Three distinct kinds of single strand breaks are 
recognizable (111) and they are due to:
1. direct attack by free radicals,
2. DNA phosphotriester formation and hydrolysis,
3 base alkylation, depurination or depyrimidination, and
subsequent hydrolysis of the adenosinephosphate site.
Type 1 effects are commonly associated with quinone 
type antibiotics. Paoletti has already suggested that the 
phenoxy radical generated by the action of peroxidase, could 
be considered responsible for single DNA strand breaks 
caused by various hydroxyel 1ipticines (112). It is thought
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that in the course of oxidising 9-hydroxye11ipticine to the 
phenoxy radical, an oxygen molecule is reduced to a reactive 
"superoxide ion" which then reacts with water to give a 
hydroxyl radical. The latter is highly reactive and can
easily cause DNA strand breaks. This argument is dependent 
on the validity of the "iminoquinone mechanism” (Figure 23) 
which as already mentioned, is doubted by Archer. On the 
other hand, if these free radicals are involved in the 
damage of DNA, they shall also initiate lipid peroxidation 
as observed in the case of the quinone type antibiotics. 
Thus further work is required for the charactisation of the 
cause of single strand breaks that is associated with
ellipticine adminstration.
2.2.5 DNA double strand breaks by ellipticine 
(involving DNA topoisonerase II)
The recent demonstration that the nuclear enzyme DNA 
topoisomerase II mediates DNA scission in cells exposed to 
intercalative anticancer agents creates important new
opportunity for understanding how the drugs work (109). 
Regulation of DNA topology is of critical importance to 
normal cellular function, and one of the principal means by 
which the cell accomplishes this is by DNA topoisomerases I 
and II (113-115). Both of these nuclear enzymes occur in all 
living cells although more is known about mammalian
topoisomerase II than topoisomerase I. There are really two
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components to the action of topoisomerase II. The first is 
the ability to concurrently and reversibly cleave both 
strands of doubly stranded DNA, and the second is its 
"strand passing" activity which facilitates the formation 
and deformation of the supercoiling structure of DNA 
(114-115). The first indication that DNA topoisomerase II 
might be involved in the action of anticancer agents came 
from studies of adriamycin and ellipticine by Ross et. al. 
(116-117). In the presence of these intercalating agents, 
the cleavable complex formed between the DNA and the enzyme 
fail to reseal, resulting in DNA double strand breaks. 
Although little is known about the mechanism of this action, 
it is established that intercalation mode of DNA binding is 
not a pre-condition for the process (118). In fact, a 
different class of antitumour agents, the
epipodophyllotoxins have been shown to inhibit strand 
passing activity and potently induce DNA cleavage by 
topoi somerase II j_n. vi tro (119-120). This suggests that the 
drug might elicit its action via some form of interaction 
with the enzyme. Interestingly, Pommier et. aj.. have reported 
that amsacrine (m-AMSA) stimulates the protein-associated 
DNA strand breaks at all concentrations, whereas
2-methy1-9-hydroxyel1ipticium acetate stimulates cleavage at 
low concentrations and inhibits the effect at high 
concentrations (121). Ross argues that by creating 
topological distortion in DNA, by extensive intercalation, 
enzyme recognition of DNA binding site is interfered with,
-47-
thus disfavoring the DNA double strand breaking process 
mediated by Topoisomerase II. The question is: how then,
does a higher concentration of amsacrine, another effective 
intercalator, not similarly inhibit topoisomerase II 
mediated double strand breakage?
The mechanistic studies of the antitumour activity of 
ellipticine have been significantly promoted to a higher 
level since the recent identification of topoisomerase II as 
a probable intracellular target. It is now imperative to 





3.1 Basis of the project
It is acknowledged (67,122) that the poor water 
solubility of the ellipticines has been a major drawback in 
their widespread acceptance as clinically useful drugs. For 
instance, Paoletti e£. *lL* (123) terminated a human clinical 
study with 9-hydroxyel1ipticine (which is known to be one of 
the most active in the series) simply because insufficient 
doses of the drug were translocated from the injection site 
to the tumour (122).
While studies of the pharmacokinetics of these
antitumour agents within the body have been few (68), it has 
been demonstrated that those which do not bear a polar 
substituent (e.g. ellipticine and 9-methoxyel1ipticine) bind 
strongly to acidic lipids (124-125) and therefore remain 
relatively longer in the lipid layers of the cell. This 
so-called depot effect leads to prolonged interaction with 
certain enzymes at the microsomal membrane and, also,
causes changes in membrane. permeability. Together, these 
features may lead to cell death. Less lipid-soluble 
ellipticines, e.g. 9-hydroxy- and 9-amino-el1ipticine, are 
adsorbed on the membrane surface and in this way 
discouraged from penetrating the membrane and reaching the 
nucleus of the cell where DNA occurs (126).
In this respect, it seems that a balance needs to be
struck between 1ipophi1icity and hydrophi1icity. One 
possibility would be to introduce an alkyl chain tipped with
-49-
an amino group onto the ellipticine nucleus and this has the 
important feature that the polar group is isolated by the 
alkyl chain from the TT-system of the tetracycle (direct 
substitution of polar groups onto the nucleus usually leads 
to a reduction of anticancer effect). In the ellipticines, 
there are eleven potential anchorage points for the chain. 
Computer modelling work with ellipticine models intercalated 
within the DNA base pair pocket suggested that substituents 
emanating from C-5, C-7 and C-8 do not seriously clash with 
the sugar-phosphate backbone of the nucleic acid (127-128). 
In this work, the objective was to investigate syntheses of
7- and 8-substituted ellipticines while my colleague, Andrew 
Ratcliffe in a separate project (55), considered routes to 
C-5 analogues.
3.2 Synthetic work towards 7-substituted ellipticine
3.2.1 Attempts to synthesise the ellipticine 1 1  <6 using 
the Sainsbury-Weerasi nghe route
ellipticines 1 1 6  and JL JL Z? . Several 7-subst i tuted
116 R = H
Our intended targets were the 7-substituted
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ellipticine derivatives, such as 7-chloro- <£>5, 7-fluoro- 
*£>«£» and 7-methy1-e11ipticine <£> have previously been 
prepared (53) by the Sainsbury-Weerasinghe route (Figure 
15). Our plan was to use this route to prepare the 
pyridocarbazole 1 1 «£> and first to condense the aldehyde 
*£»0 with the appropriate o-subst i tuted ary 1 hydraz i ne 1 JL €3 
in order to provide the hydrazone 1 1 . Through the
implementation of a Fischer indolisation reaction, this 
hydrazone would then form the pyr idyl indole 1 . 2 0  and in 
several further steps, the structure of the ellipticine 
JL2  1 could be built up and converted by reduction into the 
target compound 1 1 <£» (Figure 25) .
Accordingly the aldehyde «£>0 was synthesized by a 
method (55) regularly employed in this laboratory. A 
Wi tt ig-Horner reaction between 3-acety lpyr id i ne 2 6  and the 
activated phosphonoester JL 2 2  gave the unsaturated ester 
1 2 3 ,  and this product was reduced by catalytic 
hydrogenation to yield the ester 1 2 ^ 1 .  Reduction of this 
with lithium aluminium hydride in tetrahydrofuran afforded 
the alcohol 1 2 5  which was then oxidised by the Swern 
technique to furnish the aldehyde dbO (Figure 26).
Next we attempted to prepare the hydrazine 1 I S  
(Figure 27). Thus o-ni troc i nnamic acid 1 2 6  was first 
converted to the amide 1 2 7  via its acid chloride. The 
crude product was directly reduced over palladium on 
charcoal to afford the aniline 1 2 S  in good yield.
-51 -
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Unfortunately, attempts to convert the latter compound 
to the corresponding hydrazine JL JL £3 have all failed. For 
example, when the aniline 1 J2 £3 in an hydrochloric acid 
solution was diazotised with sodium nitrite under normal 
conditions (129), it gave an orange solution. Treatment of 
this solution with sodium sulphite did not result in 
■formation of the hydrazine JL JL £3 ; instead the phenol J. 3  O  
was produced. This suggests that the diazonium salt JL Z2. 
has been formed, but did not undergo reduction by the action 
of sodium sulphite. In a separate attempt, the aniline 
J L 2 S  was again diazotised and now was treated with tin(II) 




suspension was formed immediately. The precipitated solid 
was collected, but this on treatment with base gave only a 
dark tarry product which we could not characterise. Facing 
the difficulty of obtaining the o-substituted 
pheny 1 hydraz i ne 1 1 8  at the beginning of a multi-stage 
synthesis, we decided that an alternative route to our 
ellipticine targets was necessary.
3.2.2 The synthesis of carbazoles functionalised at C-8
The modified Cranwe11-Saxton synthesis (Figure 17) is 
known as an efficient means of entry to some ellipticine 
compounds, e.g. (Figure 20). The key step in the
approach being the formation of 1,4-d imethy lcarbazoles 7 5  
from the corresponding indoles 7 5 .  We were interested in 
adapting this strategy as the route towards our targets and 
thus we needed to devise a preparation of the appropriately 
C-8 functionalised carbazoles. It was originally anticipated 
that a C-8 substituent would perhaps be introduced 
regio-selectively into the 1,4-dimethylcarbazole system via 
rearrangement reactions of the N-al lylcarbazoles 1 5 1  and 
1 5 2  (Figure 28). Although such a transformation has not 
been demonstrated previously with carbazoles, a similar 
reaction of N-al 1 y 1 i ndo 1 e 1 5 5  is known (130). Here the 
product is 3-al 1 y 1 i ndo 1 e 1 5  <£> , but the rearrangement is 
thermally induced and requires pyrolysis of the indole 
1 5 5  at 470 °C (Figure 29).
-54-
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132 R = OMe 134
Figure 28
Of more practical importance is the report by Kazaki
et al. (131) that the same transformation can be achieved
under a milder condition by treating the N-allylindole
JL3:5 with various Lewis acids. These include zinc
n
chloride, titanium tetrachloride and antimony pe^tachloride, 
but the most effective is aluminum trichloride.




We decided to investigate this rearrangement chemistry 
with 9-(N)-ally1-1,4-dimethylcarbazole JL3  JL which was 
readily prepared in two steps: indole 2 5  was allowed to
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react with hexa-2,5-dione Z? ^  in the presence of
4-to 1uenesu1phonic acid monohydrate to give 1,4-dimethyl- 
carbazole . This product was then N-allylated using
sodium hydride and allyl bromide (Figure 30). An attempt to 
thermally rearrange the N-al 1 y 1 carbazo 1 e JL 3  JL failed and 
the starting material remained largely unchanged after being 
heated in xylene for 30 h under reflux. Next the reaction 
was repeated in dichloromethane at room temperature using 
aluminum trichloride as catalyst and after 9 h, two products 
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They were assigned as the two isomeric products JL 3  9  
and ±*3 0  and the locations of the allyl groups in the two 
compounds were deduced from n.m.r. spectroscopic data and 
later confirmed by nuclear Overhauser experiments. In the 
spectrum of the 3-allyl isomer 1 3 9 ,  the methylene protons 
of the allyl group give rise to a multiplet at 3.6 ppm, 
which if irradiated causes enhancements of intensity of the 
resonance of the C-4 methyl protons <at 2.8 ppm) and that of 
H-2, a singlet at 7.0 ppm. A second irradiation was carried 
out on the C-4 methyl resonance at 2.8 ppm and this resulted 
in enhanced signals at 8.2 ppm (H-5) and at 3.6 ppm (the 
signal of the allylic methylene protons). Irradiation of the 
second methyl resonance at 2.5 ppm caused an enhancement of 
the intensity of the 1H resonance at 7.0 ppm due to H-2, but 
did not affect any other aryl proton signal. These results 
thus conclusively show that the carbazole is substituted by 
an allyl group at C-3. In the case of the other isomer 
± * 3 0 ,  assignment of the n.m.r. signals follows by
comparison with those made for 1, 4-d imethy lcarbazole 2*3 
and for the 3-allylated compound ± 3 9 .  For example, as is 
general in such compounds, the signal due to the H-5 proton 
occurs at lowest field of all of the aryl proton resonances 
while those due to H-7 and H-8 coincide to give a multiplet 
at ca. 7.2 ppm. In a nuclear Overhauser experiment, 
irradiation of the methylene protons signal in this compound 
(at 3.8 ppm) produced an enhancement of intensity in both 
the H-5 signal (at 8.1 ppm) and in the multiplet (at
-57-
7.2 ppm) due to the resonance of H-7 (and H-8). We presumed 
that the formation of these two products arose from two 
consecutive C3,33-sigmatropic processes, i.e. an aza-Cope 
first, followed by a Cope rearrangement (see also p.66-67) 
(Figure 31). As a result, these products are expected, but 
we were surprised that none of the 8-al lylcarbazole 1 3 3  
had formed. We then turned our attention to the 
6-methoxylated carbazole 1 3 2  since in this case, the 
6-position is now occupied by a methoxyl substituent and the 
required 8-allylated compound ± 3 4  should now be available 
through an analogous rearrangement reaction.
The N-al ly lcarbazole JL 3 2  was prepared from
5-methoxyindole 1 3 7  and hexa-2,5-dione 374 in the usual 
way, and the product ± 3 8  N-allylated using sodium hydride 
and allyl bromide. The indole ± 3 3 7  was itself prepared 
according to a procedure recommended by Lloyd et. al.. (132); 
in which the o-nitrotoluene ± 4 ±  is condensed with 
tripiperidinomethane under thermal condition to give the 
p iper id i nostyrene ± 4 2 .  Without purification, the latter 
was directly transferred to a bufferred (ammonium acetate) 
solution of titanium(III) chloride with the aid of acetone 
as a solvent. Under this condition, the nitro group was 
immediately reduced in. situ by the action of t i tan i urn (111) 
chloride to give an amine ± 4 3 .  This compound in turn 
afforded the indoline ± 4 4  v i a an intramolecular 
nucleophilic attack of the amino group at the ^-position of 
the styrene. Elimination of piperidine from the indoline
-58-
took place in the same pot to furnish the required indole 
1 3 3 7  (Figure 32).
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In our hands, another product was also obtained in
this reaction and this was identified as the
bi s-i ndol yl propane JL 5  2  . A similar product JL5-3- has also 
an-
been isolated byAother worker (133) in this group when he 
prepared 6-methoxyindo1e JL5  X using the same procedure. 
These bis-indolyl products arise from a side reaction 
between the desired indoles and the acetone that is 
recommended as a co-solvent in the experiment; however, no 
mention of the formation of these rather obvious products 
was given in the original reference. The problem is simply 
avoided when acetone is replaced by tetrahydrofuran as the 
transfer solvent.
The condensation reaction between the methoxyindole 
X 3 2  and hexadione ^ was then carried out and the 
conventional extractive work-up was replaced by the use of 
column chromatography. In this way, the whole procedure 
could be simplified and loss of product minimised. The 
al ly lcarbazole X 3 2  was next heated under reflux in xylene 
for 24 h, but the starting material remained largely 
unchanged. In contrast, when it was treated with aluminum 
trichloride in dichloromethane, all starting material was 
consumed after 7 h. Usual work-up procedure then gave three 
products which were isolated in 62%, 24% and 9% yield
respectively. The structures of these compounds were 
established as the carbazoles X 3  ^  , X 5  5  and 1 5 6  
respectively (Figure 33).












In the 1H n.m.r. spectrum o-f the 8-al ly lcarbazole 
1 3 ^ ,  two doublets at 6.91 and 6.89 ppm are quite typical 
of the H-2 and H-3 signals of 1,4-dimethylcarbazoles. 
Obviously then, the 2- and 3-positions remain unsubstituted 
in this product. Two additional doublets at 7.57 and 
7.09 ppm, each has a coupling constant of J.-2.4 Hz, 
indicative of a "rneta.* relationship and are therefore 
assigned as the resonances of H-5 and H-7. By way of 
contrast, the ^H n.m.r. spectrum of the 3-allyl isomer 
A 5 55 exhibits a standard first order AMX pattern for 
resonances of the aryl protons of ring A at 7.75(d), 7.36(d) 
and 7.05 ppm (dd). These resonances resemble those of the 
parent and are assigned to the signals of H-5, H-8 and H-7
- 6 2 -
protons respective1y. The one remaining aryl proton signal 
at 7.02 ppm appears as a singlet and is due to the resonance 
of the H-2.
The presence of a chlorine atom in the third product 
JL S  «£> is evidenced by its mass spec trometr i c data. For 
example, the molecular ion appears as two peaks at m/z 301 
and 303 in the ratio 3:1; this is to be expected for the 
natural abundance of the chlorine isotopes. The n.m.r.
spectrum of the chloro compound also resembles that of
the 8-al lylcarbazole JL3«3- except that it does not reveal 
the characteristic spin-spin pattern for the resonances of 
an allyl group. Instead, there is now a 3H doublet at
1.59 ppm, a pair of 1H double doublets at about 3.25 ppm and 
a 1H multiplet at 4.43 ppm. These data are consistent with 
the presence in the molecule of a C^CHCCllCH^ group located
at C-8. Results from decoupling experiments also affirmed
this assignment.
Once again, aluminum trichloride was found to be the 
only effective Lewis acid among many tried in causing the 
rearrangement of the N-allylcarbazole. Ethyl aluminum 
dichloride, zinc chloride, boron trichloride and boron 
trifluoride etherate all had little effect on the
N-al 1 y lcarbazole ± 3 2  even after long reaction times. 
Similarly, this substrate was unchanged after treatment with 
trifluoroacetic acid. We also observe that, with aluminum 
trichloride, the effect of solvent is crucial; reactions in 
non-polar solvents like toluene and 1,2-dich1oroethane are
- 6 3 -
similar to those in dichloromethane and rearrangements to 
C-allylated products result. However, when nitromethane was 
employed, the course of the reaction changed completely; the 
starting material was deallylated within 45 min at 0 °C to 
yield the simple carbazole 1 3 0 .
Although it was not our intended objective to 
investigate the mechanistic aspects of this rearrangement 
reaction, we were still interested to know if it was an 
inter- or intra-molecu 1ar process. Surprisingly, intra­
molecular [3,31-sigmatropic processes such as the aza-Cope 
rearrangements have not been reported in the case of 
carbazoles, but Fries rearrangements of acylated carbazoles 
and the equivalent aluminum trichloride mediated 
Friedel-Crafts acylations of carbazoles have been studied 
before (134). In fact, whether a Fries rearrangement is an 
inter-, intra-molecular or "between the two" process has 
long been an arguable subject (135-137). A photo-Fries 
process has been carried out by Ivanov et. aj_. (138) on 
N-acetylcarbazole 1 5 7 .  After irradiation of a solution of 
this substrate in isopropanol with ultra-violet light for 
just 80 s, the C-acylated isomer 1 5 0  was obtained (Figure 
34). The course of this reaction is, however, solvent 
dependent and in cyclohexane, the two acylated carbazoles 
1 5 0  and 1 5 9  were obtained in an equal molar ratio 
(139). In addition, a Fries rearrangement of N-acetyl- 
carbazole 1 5  37 has been reported by Yurev et. a_l.. (140).
Here, the only product isolated was 3-acetylcarbazole 1 5 9
in 63% yield and the conditions employed were nitromethane 
with 1 mol equivalent of aluminum trichloride at 60-90°C. 
Interestingly, the same workers also reported a 
corresponding Friedel-Crafts type acylation (141) in which 
carbazole ±<£»0 in nitromethane was treated with acetyl 
chloride (2 eqv.) and aluminum trichloride (1 eqv. ) at 90 °C 
for 5 min and a mixture of C- and N-acetylated products 
1 5 7  - 1 5 9 ,  1<£>1 were obtained (Figure 35).





In order to make a judgement between inter- and 
intra-molecular rearrangements in the case of our 
N-allylated carbazoles, we designed a simple cross-over 
experiment in which equal amounts of the N-al1y1carbazo1e 
± 3 ±  and its 6-methoxy-des-al 1 y 1 derivative ±1383 were
-65-
treated together with 2 mol equivalents of aluminum 
trichloride. Three compounds were eventually obtained and 
were shown to be identical with the starting 
methoxycarbazole JL 3  ©  and the two rearranged isomeric 
products X 39* and JL 4  O . The recovery of the
unchanged methoxycarbazole X Z3£3 was 99% and no
crossed-over products were observed. This result suggests 
our allyl rearrangement is an intramolecular process for if 
an intermolecular Friede1-Crafts type allylation had taken 
place, attack of the free ally1-aluminium chloride complex 
would have taken place preferentially with the methoxylated 
carbazole rather than with its less electron rich parent.
In light of the outcome of this cross-over experiment, 
we propose that the rearrangement processes we observe
involve charge-induced intramolecular C3,33-sigmatropic 
shifts. In the former case, an aza-Cope rearrangement onto 
the neighbouring 8-position provides the 8-ally1-6-methoxy- 
carbazole 1 3 4 ,  whereas an aza-Cope rearrangement onto the 
neighbouring 1-position, immediately followed by another 
Cope rearrangement provides the 3-al1y1-6-methoxycarbazo1e 
J L S 5 .  Similarly, both of the isomeric products JL Z5«P and 
JL-^fO in the des-methoxy series arise from stepwise
aza-Cope and Cope rearrangements.
Although the term sigmatropic rearrangement was 
originally used by Woodward and Hoffmann for "uncatalyzed 
intramolecular processes", it has been widely employed in 
recent years to characterise many related reactions (142).
- 6 6 -
The expression “charge-induced" sigmatropic rearrangement 
was introduced after it was realized that many otherwise 
thermally mediated reactions will take place at ambient, or 
even at low temperature when an "inducing agent" is added. 
These agents include Lewis acids, transition metal catalysts 
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Figure 35
For example, Schmid et. al_. <143) established that
boron trichloride is a suitable Lewis acid for aromatic
-67-
Claisen rearrangements (Figure 36). The amount of Lewis acid 
required in this case was, however, s t o i c h^jnet r i c and 
therefore boron trichloride is not classified as a catalyst. 
Schmid e_t a 1 . (144) have also extended their work into the
analogous amino-C1 aisen series. In a typical experiment, the 
N-allyl aniline J. <£» Z2. was treated with 1.1 mol equivalents 
of zinc chloride in xylene under reflux for 4 h to give 











Hansen et_ al_. (1*45) have shown that the role of zinc 
chloride was not unique in these processes and they found 
that by maintaining the amine JL <£» 55 in 2 M sulphuric acid 
at 30 °C for 48 min, the 4-al 1 y 1 ani 1 ine 1 6 6  was obtained 
in 39% yield, alongside with a significant amount of the 
deallylated aniline 1 6  37 (21%) (Figure 38).
When the chloride X 5 ^  is treated with sodium 
hydride in dimethylformamide, the al lylcarbazole ± 3 4  is 
regenerated. Two molar equivalents of base were used for 
this reaction. Interestingly, the conjugated styrene 1 6 8  
was not obtained in the reaction and we speculate that this 
is the result of electronic effect. It is expected, for 
example, that the "acidity" of the methylene protons 
adja-cent to the ring would be reduced if the carbazole is 
present as the conjugate anion (Figure 39).
Having established a route to the 8-allylcarbazole 
X 3 ,  we then proceeded to continue with the remaining 
















reaction was first scaled up, two new products A <£» and
JL 3 ^ 0  were isolated (Figure 40). For the mass spectrum of 
JL <£> ^  , three major ion peaks at m/ z 530, 292 and 238 are 
observed. We also noticed that the n.m.r. spectrum of
this compound was very much like a composite of the relevant 
parts of the spectra of the monomeric aj ly lcarbazoles A 3  *3- 
and A S S ,  particularly in the "aromatic" region. Indeed,
the duplicated signals that are apparent in the spectrum for
the resonances of the O-methyl, C-l methyl and C-4 methyl
protons gave a strong hint of a dimeric structure. Should
-70-
this be so then the lack of AB spin-spin system of the H-2 
and H-3 proton resonances suggests that both carbazole 
monomers are either C-2 or C-3 substituted. The integral of 
the spectrum shows that only one allyl group is present, 
however two double doublets at 3.14 ppm and 3.02 ppm each 
due to a single proton resonance together with a single 
proton multiplet at 3.54 ppm signify that an addition of one 
carbazole nucleus has occurred to such a group to give a 
unit of the type:
.CH,\ /CH,A r /  2 \ c h /
I Ar' = carbazole
/
Ar nuc1eus
In support of this, a 3H doublet is observed at 
1.29 ppm. This type of structure fits both the mass spectral 
data and an elemental analysis. From the aromatic proton 
resonances, it is clear that the ring A of one carbazole 
unit has an allyl group bonded to the C-8 (double doublets, 
J*2.4 Hz, at 7.62 ppm and 6.89 ppm). Whereas the other is 
unsubstituted (apart from the methoxyl group) for its 
signals form an AMX spin-spin system. Two further 1H 
singlets are observed at 7.27 ppm and 6.99 ppm and we assume 
that these represent the signals of the remaining aryl 
protons at C-2 in one monomer and C-2 in the other. Our 
presumption is governed by the fact that we consider the 
dimer results from the addition of the 3- and 8-allylated 
monomeric carbazoles. It would not make sense to postulate 
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Figure 40
The structure of the other product JL Z? O  was similaly 
assessed. Its mass spectrum exhibits molecular ions at m/z 
566 and 568, in the ratio of 3:1, typical of the isotopic
abundance of one chlorine atom. The same duplicity was
observed for a pair of peaks at m/z 328 and 330. Other major
ion peaks at m/z 292 and m/z 238 were also present. The
assignment of the ^H n.m.r. spectrum of this product follows 
by comparison with those of the monomers JL 55 55 and JL 55 «£> 
and a similarity to that of the first dimer. One feature of
-72-
the n.m.r. spectrum of this chloro compound is the 
duplication and hence broadening of signals and this may be 
attributed to the presence of the two possible pairs of 
diastereomers in the sample. In this respect, it is 
understandable that its melting point occurs over the range 
189-195°C and is much lower than that of the parent 
structure X (241-243 °C).
The formation of these two di-carbazoly1 compounds is 
thought to be a result of over reaction. During the 
scaled-up operation, the reactant solution was more 
concentrated and the rise in reaction temperature caused by 
the complexation reaction between the N-allylcarbazole 
JL 3 J 2  and aluminum trichloride then promoted the 
rearrangement reaction and also a subsequent electrophi1ic 
substitution reaction between the C-3 and C-8 allylated 
carbazoles. This undesirable over reaction was easily 
avoided by carrying out the addition of the Lewis acid at a 
lower temperature (-30°C) and then allowing the reaction 
mixture to warm up gradually to room temperature.
3.2.3 Synthesis of the 7-substituted ellipticine 1 1 7
The allyl group of the 8-al ly lcarbazole JL was now
to be transformed to the required side chain before D ring 
of the ellipticine tetracycle was constructed. This was 






The al ly lcarbazole was first converted to the
trans-styrene JL by the catalytic action of
bisacetonitrile pal 1 adiam(11) chloride in benzene (Figure 
41). Ozonolysis of the product at -20#C provided the
8-formyl compound 1 7 2  in 79% yield after a reductive 
work-up using dimethyl sulphide. A Wittig-Horner reaction 
between this arylaldehyde JL Z?Z2. and the phosphonoacetamide 
1 was then carried out. The phosphonate was prepared
according to the procedure recommended by Landor et. al.
(146). Thus chloroacetyl chloride JL ^ 5  was coverted to the 
amide X Z? which then heated with triethyl phosphite to 
yield the required phosphonoacetamide J L ^ 3 .  It was found 
that the Wittig-Horner reaction worked best when 2 mol 
equivalents of base (sodium hydride) were used; and then the 
desired unsaturated amide JLT7 !^- was obtained as yellow 
crystalline solid in quantitative yield after stirring at 
room temperature for 24 h. The provision of an additional 
molar equivalent of base is necessary since the base also 
causes deprotonation of the carbazole. The unsaturated amide 
J L ^ ^  was next reduced over palladium on activated carbon 
at 60 psi to afford the colourless product, amide J. Z? X .
-74-
Thus the stage was finally set for the D ring 
synthesis beginning with a formylation at the 3-position of 
the carbazole JL JL . Like other el ec t r oph ilic substitution 
reactions of carbazoles, formylation largely takes place at 
the 3- and/or 6-positions which are the most electron rich 
sites next to the nitrogen atom (134). Dalton et. al_. (2) 
have prepared the 3-formylated product JL ©  from the 
















This reagent system is known to acylate ring A 
methoxy1ated carbazoles in this ring rather than in ring C 
so we chose to employ the more sterically demanding 
d i acy 1 imidazol ium reagent 1 7 9  developed by Bergman et, al.
(147) (Figure 43). This furnished the desired product JL S O  
after base hydrolysis of the intermediate N,N-diacylimid- 
azoly 1 carbazol e J L S 2 .  Unfortunately, this product was 
found to be contaminated with a diformylated compound
X S X .  The separation of these two compounds by 
chromatography was unsuccessful, nonetheless, the structure 
of this by-product was evident from the spectral data of the 
mi xture.
In the mass spectrum, for example, it gives rise to a 
molecular ion peak at m/z 408, 28 units higher than that of 
the molecular ion of the mono-formy1ated compound. In the
i
H n.m.r. spectrum, two formyl protons resonate at 10.76 and 
10.42 ppm, the original signal for H-7 in the spectrum of 
the starting material is no longer present, and the 
resonances of the first two pairs of methylene protons on 
the side chain at C-8 have also been affected by the
-76-
proximity of the carbonyl group. This causes down-f ield 
shifts of these signals from 3.37 to 3.68 ppm and from 2.77 
to 2.92 ppm.
= \  (cf,co)7o r=f=\ _______










Rather than wasting time searching for conditions 
which would effect selective ring C formylation, we turned 
tD the unsaturated compound X "7* knowing that the
conjugation between the alkenylamido side chain and the
aromatic system would lower the electron density of the
7-position and hence deactivate it towards attack by the
formylating agent XT?*?. In this way, the corresponding 
3-formyl product X S Z 3  was obtained in good yield <83%) and 
diformylated products were not detected (Figure 44).
The double bond on the side chain was selectively
reduced over palladium on activated carbon under mild
conditions (Figure 44). But if excess time was given to the 
reaction, a new component began to form. This is believed to 
be the corresponding alcohol produced as a result of the
reduction of the carbonyl group of the aldehyde I S O .  The 
Schiff’s base 1 8 4  was next prepared by heating the
3-formyl compound with excess 2-ami nodimethoxyethane at 
100°C. This product was sufficiently stable for handling 
although, in our work, we chose to reduce the crude product 
directly over Adams’ catalyst to yield the amine 1 S 5 .  
This was then N-tosylated using tosyl chloride in pyridine
to afford the sulphonamide X as colourless
solid
crystalline Ain 85% yield.
The conditions used in the formation of the D ring in 
this synthesis is analogous to the ring closure reactions 
employed by Jackson et al_. (59) for the construction of 
isoquino1ines. The limitation of the final cyclisation step
- 7 8 -
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is that it only works well on electron rich aromatic systems. 
Guthrie et. aj_. (68) have employed this method in their 
synthesis of the ellipticines <£» and (Figure 45). The
usual cyclisation conditions are 6 M hydrochloric acid in 
dioxane at room temperature overnight.
A









Fallowing these recommendations, the sulphonamide 
1 0 6  was treated with 6 M hydrochloric acid in dioxane at 
room temperature. After 55 h, all starting material had been 
consumed and the ellipticine X&Z? was obtained in about 
30% yield. The reaction was sluggish and there was evidence 
that si de-products were being formed. These impurities 
rendered purification quite tedious. In an effort to 
increase the rate of cyclisation and to minimise the 
possibility of acid hydrolysis of the amide, we decided to 
heat the reaction mixture and to use more concentrated acid. 
Accordingly, the reaction was repeated at 100°C using 10 M 
hydrochloric acid in dioxane as reagent. As a result, the
-80-
reaction time was dramatically reduced to just over 3 h. The 
product was now easily isolated in 56% yield after column 
chromatography.
Redaction of ami doel 1 i pt i c i ne 1 &Z? to the amino- 
ellipticine JL JL Z? was effected by using borane-methy 1 
sulphide complex (BMS) in tetrahydrofuran (Figure 44). This 
reagent is less sensitive towards oxygen and moisture than 
borane alone and is much more convenient to use (143). The
role of this reagent in the reduction of amides to amines
has been demonstrated by Brown et. aj_. (149). Thus, 
following their literature conditions, the amide JL ST* in 
tetrahydrofuran under reflux and protected by an atmosphere 
of nitrogen, was treated with a 2M solution of the complex. 
The amide was completely reduced in 45 min and after acid 
hydrolysis of the resulting borane-amine complex, the final 
amine JL 1. 'Z? was obtained in an unoptimized 51% yield.
The formylcarbazole JL S 3  was also converted into the 
correspond i ng Schiff*s base 1 8 8  but when it was 
hydrogenated over palladium on activated carbon, the 
expected amine 1 8 5  was not obtained. In contrast, sodium 
borohydride reduction of the imine in ethanol solution 
readily provided the amine JL which was then tosylated
as before, to afford JL«PO as a yellow solid (Figure 46). 
Attempts to ring-close this product to the ellipticine 
JL *P 1 failed and the tosylated compound 1. O  gradually
decomposed in the presence of concentrated hydrochloric acid



















effect on the carbazole nucleus caused by conjugation 
between it and the unsaturated side chain. Indeed, no 
tetracyclic products were observed even after the amine was 
treated with acid at 10 0°C for 24 h. Nevertheless, this 
carbazole A O  can be easily reduced over 10% w/w
-32-
palladium on activated carbon to afford an alternative 
source of the useful intermediate 1 Q 6  in quantitative 
yield.
3.3 Synthetic work towards 8-substituted ellipticine
3.3.1 Synthesis of C-5 and C-7 substituted carbazoles
Parallel to our work on the aza-Cope rearrangement of 
N-allylcarbazoles, we have also investigated the 
rearrangement chemistry of the O-al 1 y 1 carbazole ± ^ 2 .  The 
tactic was again to exploit the presence of a hetero-atom 
substituent as an internal "handle" for the introduction of 
another substituent onto the neighbouring position(s) which 
may otherwise be less readily accessible. Here we are 
interested in the C-7 allylated carbazole. The required 
material in this investigation was prepared from 3-methyl-
4-nitrophenol. This was easily allylated by reaction with 
allyl bromide and sodium bicarbonate in acetone before being 
subjected to the same conditions employed previously in the 
synthesis of 5-methoxyindole (i.e. from 1 4 5  to X in
Figure 32). The al ly loxyi ndole thus obtained was
reacted with hexa-2,5-dione to furnish the desired carbazole
There is now an uncertainty over the regio-selectivity 
of the rearrangement process as both the 5- and 7-positions
are available to accomodate the allyl qroup. A similarA
- 8 3 -
TT
192
situation had also been encountered by Julia et. *»!_. (150).
In their synthesis of lysergic acid analogues, 4,5-di- 
substituted indoles were required. The 5-al1y1oxyindole 
J L 9 3  was thus prepared and subjected to a thermal Claisen 
rearrangement. The 4-allylindole JL *P ^  was obtained 
regio-specifically in 91% yield (Figure 47). The selectivity 
was apparently determined by the much higher electron 






In carbazole, this difference in electron density 
between the 5- and 7-positions also exists and there is a 
preference for bonding to the C-5. Indeed, after heating the 
al ly 1 oxycarbazol e JL Z2. for 60 h, under reflux in xylene,
-84-
only the 5-allyl isomer JL *!P S  was isolated in 80% yield 
(Figure 48). The possible steric interaction between the C-4 
methyl group and the allyl group in the transition state 
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Figure 48
We next proceeded to investigate a charge-induced 
rearrangement reaction. Hence the a 11y 1oxycarbazo1e ±*5*2?
-85-
was treated with 1 mol equivalent of boron trichloride in 
dich1oromethane at -25°C. The reaction was complete in 
30 min and two products were isolated in 83% and 12% yield. 
The major product was shown to be identical with the
5-al 1 y 1 carbazol e JL 5  , obtained previously. Thus its aryl
substitution pattern was readily determined from the
i
H n.m.r. spectrum in which there are four doublets
representing the signals of the four aromatic C-H protons, 
two of which are at 7.02 and 6.81 ppm, and are assigned to 
be the ortho-coup 1ed H-2 and H-3 protons. The other two 
doublets at 7.29 and 7.05 ppm, share a coupling constant of 
J[=8.4 Hz and are assigned as the ortho-coupled H-7 and H-8 
resonances.
The assignment of the n.m.r. spectrum for the minor 
isomer 1 9  6  was also straightf orward; there are for 
example, two doublets, sharing a coupling constant of 
J=7.3 Hz, at 7.08 and 6.87 ppm. These arise from the
resonances of the H-2 and H-3 protons respectively. There 
are also two singlets at 7.61 and 7.20 ppm; the downfield 
signal is associated with the resonance of H-5 and the other 
with that of H-8 . The interesting outcome of this reaction 
is that the presence of boron trichloride has greatly 
reduced the reaction time and temperature and increased the 
yield. The most significant fact is however that it has also 
affected the regio-specificity of the reaction. Although the 
7-substituted isomer obtained could be used as a suitable 
starting material for preparing the 8-substituted
- 8 6 -
ellipticine JL 9 7  , we have yet to find ways of controlling 
the amount of undesired 5-allylated product
O-Methy 1 at i on <151) of the carbazole X *P <£» to give 
1 *P Q  was achieved using methyl iodide and sodium hydroxide 
in a mixed dichloromethane/water system with benzyl 
triethy1ammoniurn chloride as the phase transfer agent 
(Figure 49). The alternative N-methylated product was not 
obtained from this reaction, however; the N-alkylation of 
certain carbazoles under similar conditions has been 
reported previously (152).
HO MeOMe!, NqOH
196 I ? 8
Figure 49
3.3.2 Synthesis of the amidopropyl indole 2 0 8
Another attempt to prepare the 8-substituted 
ellipticine X*PZP was also carried out. Here, the key 
intermediate was to be the f unc t i onal i sed carbazole, 2 0 0 . 
For this the precursor should be the indole X^ P*? and we 
anticipated to obtain this compound by the cyclisation of a 
suitable aniline 2 0  1 (Figure 50).
-87-
The formation of indoles from the corresponding 
ani1inoaceta 1dehyde acetals via an intramolecular ring 
closure is attractive and such reactions have been studied 
in recent years (153-154). This route is particularly useful 
for preparing 2,3,7-unsubstituted indoles bearing electron 
donating groups in the aromatic ring. A potential synthesis 







disfavours closure a t here ( C - 2 )
Figure 50
Although, in theory, cyclisation can take place at the 
two available ortho-positions in the aniline 2  O  JL , it is 
expected that one of them is not easily accessible due to
-88-
the presence of the sterically demanding side chain at its 
neighbouring position. In practice, the benzaldehyde 2  O  2  
was efficiently converted to the cinnamic acid 2 0 3  by 
reaction with malonic acid in pyridine and piperidine (155). 
At this stage, the acid 2 0 3  can either be reduced to give 
the amino propionic acid 2 0 4  or converted into the amide 
2 0 5 .  It was noticed that the amine 2 0 4  actually exists 
in its zwitterionic form as evidenced by its exceptionally
high melting point (decomp. 276°C) and its spectroscopic
data. Thus the IR spectrum exhibits a broad band at
2800-2400 cm”1 indicating quaternary N-H streching. The 
n.m.r. spectrum shows no carboxylic acid proton 
resonance, but a broad peak is present at 6.5-5.1 ppm, 
ranging across 50 Hz and integrating to three protons (which 
are exchangeable with the deterions of deuter^ated water).
The amide 2 0 5  was formed by treatment of the acid 
first with thionyl chloride, and then with diethylamine. 
Reduction of this amide over palladium on activated carbon 
furnished the substituted aniline 2 0 6  in good yield. This 
product was N-sulphonylated using methyl sulphonyl chloride 
in pyridine as reagent and the anilide 2 0 2  was formed in 
82% yield. Alkylation of the latter by 2-bromodiethoxyethane 
and sodium hydride provided the ani 1 inoacetal 2 0  1 as a 
colourless oil (76%). In the literature examples, the last 
ring closure reaction is normally achieved by the action of 
a Lewis acid such as titanium tetrach1oride (154). We 































chloride in dry toluene at room temperature. After stirring 
under nitrogen for several hours, tic analysis of the 
reaction mixture indicated all starting material has been
consumed and a mu 11i-component product mixture was obtained. 
The n.m.r. spectrum of this crude mixture exhibits a 
resonance at 10.2 ppm indicating the presence of an 
aldehyde. This result points to the fact that the ring
closure step had not occured and formation of an aldehyde 
could be a result of deprotection of the acetal function.
The reaction was therefore repeated at higher temperature in 
the hope of achieving cyclisation. However, a best yield of 
9% for the required indole 2 0 8  was only obtained as the 
only product when the reaction mixture was heated to 110 #C 
for 20 min. Under these conditions the majority of starting 
material seemed to have polymerised to give a dark tarry 
residue. At this stage, it was decided that this work should 
be postponed so that we could concentrate our efforts on the 
other more promising route to 7-substituted el 1ipticines, 





Chemicals, solvents and reagents were purified and 
dried, where appropriate, before use by standard methods. 
Preparative column chromatography was normally carried out 
on silica gel 60 GF7736 (E. Merck) or on alumina (Camag) 
(Fisons 100-250 mesh). Thin-layer chromatography <tlc) was 
carried out routinely on silica gel 60 GF254 (E. Merck).
Proton ( n.m.r.) and Carbon-13 ( n.m.r.) nuclear
1
magnetic resonance spectra were recorded for deutei^ated 
chloroform solutions, unless stated otherwise, on a JE0L
GX270 instrument. Chemical shifts are expressed in ppm
 ^ downfield from tetramethylsilane (TMS) as standard and
coupling constants (J) in Hz. Ultra-violet/visible spectra 
(UV) were recorded for 95% ethanolic solutions on a 
Perkin-Elmer Lambda-3 spectrophotometer. Infra-red <IR) 
spectra were measured as Nujol mulls (N), chloroform 
solutions (S) or liquid films <L), on a Perkin-Elmer 1310 
instrument. Mass spectra (MS) were recorded on an A.E.I. 
MS12 mass spectrometer at 70 eV. Mass to charge ratios are 
quoted and their relative intensity (%) are enclosed in 
parentheses.
Normally, where solvents had to be removed, a rotary 
evaporator operating at water-pump pressure was employed: 
exceptions to this routine are noted. Petroleum ether (.6o-^o°y
w as used.
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Diethyl 3- ( 2-am inophenyl ) propi on am i de JL 2  ©  . —  A
solution of o-nitrocinnamic acid (19.3 g, 100 mmol) in 
thionyl chloride (100 cm^) was heated under reflux for
2.5 h. Excess thionyl chloride was removed. The residue was 
dissolved in dry benzene (150 cm^) and efficiently stirred 
at 0 . To this solution, was added dropwise diethylamine
O
(17.5 g, 250 mmol). The resultant mixture was stirred at 0 C 
for 30 min and at 7 0 °C for 3 h. The solvent was then removed 
at ambient temperature. The residue was taken up in ethyl 
acetate (250 cm3) and the solution was washed with water (2x 
100 cm^), and then with saturated brine (100 cm^). The dried 
(MgSO^l organic layer was then hydrogenated in the presence 
of palladium (10% on activated carbon) (0.2 g), at 100 psi. 
The hydrogenation mixture was filtered through a bed of 
celite to remove the catalyst and the filtrate was 
evaporated to dryness. Crystallisation of the product from 
petroleum ether gave the title compound as a colourless 
solid (20.2 g, 92%), m.p. 69°C, IR(N) 3400, 3340, 3250 and
1600, 1H n.m.r.(100 MHz) 7.12-6.92 and 6.80-6.20 (4H,m,
Ar-Hs), 4.07 (2H,br s,NH2), 3.47-3.08 <4H,2q,J=7.1 Hz,
N(CH2CH3)2 ), 3.00-2.29 (4H,m,CH2CH2C0NEt2), 1.17-0.96 (6H,
2t,J=7.1 Hz,N(CH2CH3)2 ), Acc. MS(m/z) 220.158(M*, 81.2%;
calc. 220.153), 148.075(62.1%), 147.067<41.7%), 119.074
(67.3%).
Attempted preparat i on of hvdraz i ne 1 . 1 ©  :
(I) using tin(II) chloride as the reducing agent. —  To
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concentrated hydrochloric acid (6 M, 15 cm3), powdered 
amidopropy1 ani1ine 129 (2.2 g, 10 mmol) was added in
portions. The resultant solution was stirred at 0 #C as a 
solution of sodium nitrite (0.8 g, 11 mmol) in water (3 cm3) 
was added dropwise. The mixture was stirred at 0 °C for 
10 min. A solution of tin(II) chloride (2.28 g, 12 mmol) in 
concentrated hydrochloric acid (6 M, 0.5 cm^) was gradually 
introduced causing the formation of a heavy yellow paste. 
After stirring at room temperature for 30 min, the mixture 
was filtered under suction and the solid which was collected 
then stirred in a mixture of aqueous sodium hydroxide (40%, 
50 cm^) and ether (50 cm^) at 0°C. The aqueous layer was 
separated and extracted with more ether <2x 25 cm^), these
combined extracts and the ether layer were concentrated to 
about 20 cm^. Hydrogen chloride gas was bubbled through the 
cooled ether solution, which was later diluted with more 
ether (50 cm^), washed with saturated sodium hydrogen
carbonate solution (30 cir? ), water (2x 30 cm^ ) and saturated 
brine (30 cm3). The dried (MgSO^) organic layer was 
evaporated to afford a red viscous oil which could not be 
character i sed.
(II) using sodium sulphite as the reducing agent. —  To 
the diazotised solution prepared as described in (I>» at
0°C, was added dropwise a cold solution of sodium sulphite
(2.66 g, 21 mmol) in water (6 cm^). The mixture was then
stirred at room temperature for 60 min and at 60 °C for 
30 min. It was again cooled to 0°C. The solid precipitate
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was filtered and recrystallised from ethanol to yield a 
colourless solid which proved to be diethyl 3-(2-hydroxy- 
phenyl ) propionamide 1 3  0  (0.47 g, 21%), m.p. 127°C, IR(N)
3160, 1600, 1590 and 1260, MS(m/z) 221(M*, 80%), 204(20%),
149(26%) and 120(40%).
Tripi peridi nomethane. —  Piperidine (153.3 g,
1.8 mol), triethyl orthoformate (133.4 g, 0.9 mol) and 
acetic acid (3.6 g, 0.06 mol) were combined in a 
three-necked round bottom flask equipped with a thermometer 
and a steam-jacketed condenser. The reactants were gently 
heated to reflux (initial boiling point of the mixture was 
ca. 110*0 for 12 h. The by-product, ethanol was allowed to 
evaporate through the steam-jacketed condenser during the 
reaction. After the boiling point of the reaction mixture 
had risen above 145°C (12 h), the heat was discontinued and 
the mixture was allowed to cool to room temperature 
overnight. Lower boiling by-products were removed on a 
rotary evaporator and vacuum distillation of the concentrate 
firstly afforded N-formylpiperidine (20.1 g), b.p. 55-60*C/ 
0.2 mm Hg, which was followed by a fraction consisting of
the colourless title compound (67.1 g, 42%), b.p. 135-145°C/
156
0.2 mm Hg (lit., 98-106°C/0.05-0.1 mm Hg), H^ n.m.r. (60 
MHz) 3.12 (lH,s,CH), 2.57 (12H, m, 3x (CH? NCt^ .) ) , 1.42
(18H,m,3x - (CH2>3 -).
3-Methyl-4-nitro(prop-2-enyloxy)benzene 1<4 5  . —  A
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mixture of 3-methy 1 -4-n i trophenol (61.2 g, 400 mmol), 
anhydrous potassium carbonate (66.2 g, 480 mmol) and 
distilled allyl bromide (58.0 g, 480 mmol) in acetone 
(800 cmB) was heated under reflux for 6 h. The reaction
mixture was cooled to room temperature and the inorganic
precipitate was filtered off, then the filtrate was
evaporated to dryness. The residue was taken up in ethyl 
acetate (300 cmB) and washed with water (2x 150 cm^),
saturated brine (150 cm^), dried (MgSO^) and the solvent 
removed. Crystallisation of the residue from petroleum ether 
afforded the title compound as a colourless solid (71.8 g, 
93%), m.p. 34°C, IR(N) 1600, 1580, 1320, 1250, 'h n.m.r.
8.09 (lH,m,H-5), 6.81 (2H,m,H-2 and H-6), 6.04 (lH,m,
CH^CHj), 5.40 (2H,m,CH=CH2), 4.61 (2H,m,0CH2>, 2.62
(3H,s ,CH3), MS(m/z) 193(M*>, 176, 41(100%).
5- (Prop-2-eny 1 oxv) indole 1 "TS*. —  A mixture of 
nitrotoluene 145 (5.0 g, 26 mmol) and tripiperidinomethane 
(10.3 g, 39 mmol) was heated at 110°C for 9 h, under reduced
pressure (15 mmHg). The red viscous oil which remained was
m
dissolved in a minjum amount of acetone, and transferred to 
a separating funnel charged with a buffered mixture of 
titanium(III) chloride solution (100 cm^, 20% w/v solution 
in diluted hydrochloric acid) and ammonium acetate (4 M, 
300 cm^). The contents of the separating funnel were shaken 
for 10 min before being extracted exhaustively with ether. 
The combined ether layers were washed with saturated sodium
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hydrogen carbonate solution, water, saturated brine, dried 
(MgSO ) and the solvent removed to qive an oily residue.
Column chromatography on silica gel, eluting with ethyl
acetate in petroleum ether, afforded the title compound as 
an amber oil (2.7 g, 61%), IR(L) 3400, 3090, 1610, 1210,
1H n.m.r. 7.95 <lH,br s,NH>, 7.15 <lH,d,J=8.8 Hz,H-7>, 7.11
(lH,d,J=2.4 Hz,H-4), 7.03 (lH,m,H-2), 6.87 (1H,dd,J=2.4,
8.8 Hz,H-6), 6.43 (lH,m,H-3), 6.08 (1H,m,CH=CH2), 5.41
(lH,m,CH=CH(H)), 5.25 (lH,m,CH=CH<H) > , 4.54 (2H,m,OCH2),
13C n.m.r. 152.9, 133.8, 131.0, 128.1, 124.95, 117.4, 112.8,
111.7, 103.7, 102.15, 69.7, MStm/z) 173<M*, 45%), 132(100%), 
104(55%).
A minor by-product, a brown oil (22 mg) was also
isolated. This was shown to be 2.2-bi st3-(5-oropeny1oxv) 
indolvl Ipropane 1 5 3 ,  IR(L) 3400, 2900, 1600, *H n.m.r.
7.77 (2H,br s,2xNH), 7.14 <2H,d,J=8.8 Hz,2xH-7), 7.00
(2H,d,J=2.4 Hz,2xH-2), 6.84 (2H,d,J=2.4 Hz,2xH-4), 6.75
(2H,dd,J=8.8,2.4 Hz,2xH-6 ), 5.95 (2H,m,2x(CH=CH2)>, 5.28
(2H,m,2x(CH=C(H)H)), 5.16 (2H,m,2x(CH=C(H)H>), 4.33
(4H,m,2x(0CH2)), 1.85 (6H,s,2x(CH3)), 13C n.m.r. 151.8
(C-5), 133.9 (CH=CH2), 132.5 (C-7a), 126.6 (C-3a), 124.9
(C-3), 121.3 (C-2), 117.4 (CH=CH2), 111.8, 111.5, 105.2
(C-4,C-5,C-6), 69.8 (0CH2>, 34.6 (CMe2), 29.7 (CH3), MS(m/z) 
386 (M'*’) , 173(100%), 172 CFound: C, 77.5? H, 7.1; N, 7.05.
c2Sh?6n2°2 squires: C, 77.7; H, 6.8; N, 7.25%].
5-Methoxy i ndo 1 e 1 3  3^. —  The same procedure as
described in the previous experiment was used with 
3-methy1-4-nitroroethoxybenzene (5.0 g, 30 mmol). The title 
compound was thus obtained as a colourless solid <2.43 g, 
55%), m.p. 58 °C ( 1 i t J5,7 59 °C), IR(N) 3400, 1620, 1H n.m.r.
8.05 (1H,br s,NH), 7.39-7.12 (3H,m ,H-2,H-4 and H-7), 6.91
(1H,dd,J=8.8, 3.0 Hz,H-6), 6.55 <lH,m,H-3), 3.85 <3H,s,
0CH 3), MS(m/z) 147 (M* , 100%), 132.
1.4-Dimethvlcarbazole —  To a stirred solution
of 4-toluenesulphonic acid monohydrate (9.5 g, 50 mmol) in
absolute ethanol (50 cm^) heated under reflux in a dry
atmosphere, was added indole (11.7 g, 100 mmol) and hexa-
2,5-dione (11.4 g, 140 mmol) in absolute ethanol (200 cm^)
over a period of 90 min. The resultant mixture was heated
under reflux for another 4 h and then allowed to cool. The
solvent was removed to yield a dark red residue. Column
chromatography on silica gel, eluting with dich1oromethane
(30%) in petroleum ether, gave the title compound as a
58
colourless solid (11.8 g, 61%), m.p. 93-94 C (lit., 96 C) , 
*H n.m.r. 8.15 (1H,dd,J=7.9, 1.0 Hz,H-5), 7.86 (lH,br s,NH),
7.40 <lH,d,J=1.0 Hz,H-8), 7.38 <lH,m,H-7), 7.23 (lH,m,H-6),
7.10 (1H,d,J=7.3 Hz,H-2), 6.91 (lH,d,J=7.3 Hz,H-3), 2.82
(3H,s,4-CH3), 2.46 (3H,s,I-CH3).
1. 4-Pimethvl -6-methoxvcarbazol e 1 3 S  . —  The same
procedure as described in the previous experiment was used 
with 5-methoxyindole (14.7 g, 100 mmol) as the starting
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material. The title compound was obtained as a colourless 
solid <17.9 g, 80%), m.p. 132-133 °C (lit.? 136.5 °C), UV 
222, 275, IR(N) 3400, 1510, 1580, 1200, 800, 1H n.m.r. 7.86
<lH,br s,NH), 7.68 <lH,d,J=2.5 Hz,H-5), 7.36 <lH,d,J=8.7 Hz, 
H-8), 7.10 (1H,d,J=7.1 Hz,H-2), 7.06 (1H,dd,J=8.7, 2.5 Hz,
H-7), 6.89 (1H,d,J=7.1 Hz,H-3), 3.93 <3H,5,00^ 3), 2.83
(3H,s,4-CH 3), 2.50 (3H, s, 1-CH 3) , 13C n.m.r. C 153.7, 139.7,
134.4, 130.8, 125.0, 121.4, 117.1, CH 126.1, 120.5, 113.5,
110.9, 106.4, CH3 56.2, 20.5, 16.6, MS<m/z) 225(1*1*, 100%),
210(92%).
1.4-Dime thy 1-6- (prop-2-eny loxv) carbazole 1 9  2 .  —
The same procedure as described in the previous experiment 
was repeated now with 5-propenyloxyindole 149 (17.3 g,
100 mmol) and the title compound was obtained as a 
colourless solid (20.3 g, 81%), m.p. 140-141°C, UV 230, 244, 
255(sh), 265, 295, IR(N> 3440, 1630, 1600, 1240, 1215, 820,
1H n.m.r. 7.80 (lH,br s,NH), 7.70 (lH,d,J=2.4 Hz,H-5), 7.32
(lH,d,J=8.6 Hz,H-8), 7.09 (lH,d,J=7.1 Hz,H-2), 7.06 (lH,dd,
J=3.6, 2.4 Hz,H-7), 6.88 (lH,d,J=7.1 Hz,H-3), 6.14 (lH,m,
CH^CHj), 5.47 (lH,m,CH=C(H)H), 5.30 (lH,m,CH=C(H)H), 4.64
(2H,m,0CH2>, 2.81 (3H,s,4-CH3), 2.47 (3H,s,1-CH3), MS(m/z)
251(M+, 38%), 210(100%) [Found: C, 81.1; H, 7.0i N, 5.5. 
C17 H17NO requires: C, 81.2; H, 6.8; N, 5.6%]
1 -Dimethyl -9- (prgp.-2-enyl) carbazole JL 3  JL . —  To
a stirred suspension of sodium hydride (2.4 g of 60% in oil
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dispersion, 60 mmol) in dry dimethy1formamide (90 cm^> at 
0 *C under nitrogen, was added the carbazole 24 (9.75 g,
50 mmol) in dry d imethy If ormamide (50 cm^). After the 
addition, the mixture was stirred for a further 10 min and 
freshly distilled allyl bromide (7.25 g, 60 mmol) in dry 
dimethylformamide (10 cm^ ) was then slowly introduced. The 
resultant solution was stirred at room temperature for 
15 min and then maintained at 50°C for 6 h. After this time, 
the reaction mixture was cooled to room temperature and 
poured into cold, stirred water (300 cm^) and extracted with 
ethyl acetate (3x 200 cm^). The combined organic layers were 
washed with water (3x 150 cm^), saturated brine (100 cm^), 
dried (MgSO^) and the solvent removed. Column chromatography 
of the residue on silica gel, eluting with dich1oromethane (20%) 
in petroleum ether, afforded the product as colourless 
prisms (10.6 g, 90%), m.p. 106°C, IR(N> 3080, 3050, 3020,
1640, 1600, 900, 1H n.m.r. 8.16 (lH,m,H-5>, 7.39 (lH,m,H-7),
7.29 (lH,d,J=7.4 Hz,H-8), 7.21 (lH,m,H-6), 7.05(1H,d,J=7.3
Hz,H-2), 6.86 (1H,d,J=7.3 Hz,H-3), 6.07 (1H,m,CH=CH2), 5.12
(2H,m,CH=CH2>» 4.83 (2H,m,NCH2), 2.84 (3H,s,4-CH3), 2.74
13(3H,s,I-CH3), C n.m.r. 142.0, 139.5, 133.8, 130.9, 128.6,
124.8, 123.7, 122.4, 122.0, 120.8, 119.0, 117.1, 116.0,
108.4, 46.7, 20.8, 19.5, Acc. MS(m/z) 235.136(M*, 100%;
calc. 235.136), 208.112(13%), 194.095(95%).
6-Methoxv-l,4-d imethv1-9-(prop-2-eny1)carbazo1e 
1 3 2 .  —  The same procedure as described in the previous
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experiment was used again with methoxycarbazo1e 137
(11.25 g, 50 mmol) as starting material. The title compound
was thus obtained as colourless needles (12.2 g, 92%),
m.p. 139°C, UV 232, 245(sh), 268, 295, IR(N> 1610, 1570,
1480, 1200, 1140, 910, 1H n.m.r. 7.71 (lH,d,J=2.6 Hz,H-5>,
7.24 (1H,d,J-8.8 Hz,H-8), 7.08 (1H,dd,J=8.8, 2.6 Hz,H-7),
7.05 (lH,d,J=7.4 Hz,H-2), 6.86 (lH,d,J=7.4 Hz,H-3>, 6.05
(1H,m,CH=CH2)f 5.12 (2H,m,CH^CH^), 4.82 (2H,m,NCH2), 3.93
(3H,s,0CH 3), 2.84 <3H,s,4-CH3), 2.73 (3H,s,I-CH3),
13
C n.m.r. 155.1, 141.4, 137.9, 135.7, 132.8, 130.3, 125.7,
123.5, 122.0,119.2, 117.5, 114.9, 110.7, 108.1, 57.8, 48.6,
22.5, 21.2, MS(m/z) 265(M*, 27%), 255(50%), 254(40%),
224(33%), 213(80%), 212(60%), 41(100%) CFound: C, 81.4; H, 
7.5; N, 5.2. C18H 19NO requires: C, 81.5; H, 7.2; N, 5.3%D.
Rearrangement of 1.4-dimethv1-9-(prop-2-eny1)carbazole 
1 3  1 with al umi num trichloride i n d i ch 1 oromethane. —  To 
an efficiently stirred solution of the carbazole 131 
(235 mg, 1 mmol) in dry dich1oromethane (50 cm^) at 2 0 °C, a 
suspension of freshly ground aluminum trichloride (160 mg,
1.2 mmol) in dry dichloromethane (2 cm^) was added in small 
portions. The mixture was stirred at room temperature for 
9 h under nitrogen. It was then poured into cold water
(50 cm3) and the aqueous layer was extracted with
dichloromethane (2x 30 cm^). The combined organic layers
were washed with water (2x 30 cm^), saturated brine
(40 cm^), dried (MgSO^) and the solvent removed to give a
- 1 0 1 -
solid residue. Column chromatography on silica gel, eluting
with dichloromethane (30%) in petroleum ether, afforded two
isomeric products, A and B in that order:
Product A, 1.4-dimethy1-6-(prop-2-eny1)carbazole JL *4- O  
(108 mg, 46%), m.p. 76-77°C, UV 223(sh), 242, 250<sh), 259,
283, IR(S) 3400, 2900, 1550, 1310, 1H n.m.r. 8.07
(lH,d,J=7.3 Hz,H-5), 8.00 (lH,br s,NH), 7.24-7.18 (2H,m,H-7
and H-8), 7.12 (lH,d,J=7.1 Hz,H-2), 6.92 (lH,d,J=7.1 Hz,
H-3), 6.14 (lH,m,CH=CH2), 5.30-5.20 (2H,m,CH=CH2), 3.75
(2H,m,CH2CH=CH2), 2.84 (3H,s,4-CH3), 2.52 (3H,s,I-CH3),
MS(m/z) 235(M*, 100%), 220(40%) CFound: C, 86.7J H, 7.5? N,
5.9. C-17 Hj7 N requires: C, 86.8? H, 7.3? N, 5.95%).
Product B, 1.4-d imethy 1 -3- (prop-2-eny 1) carbazol e 1 3 9  
(96 mg, 41%), m.p. 80-81°C, UV 241, 250(sh), 262, 291, IR(S) 
3400, 2900, 1590, 1320, 1H n.m.r. 8.22 (lH,d,J=7.3 Hz,H-5),
7.88 (1H,br s,NH), 7.47-7.36 <2H,m,H-7 and H-8), 7.22
(1H,m,H-6), 7.03 (lH,s,H-2), 6.04 (1H,m,CH=CH2), 5.08-4.93
(2H,m,CH=CH2), 3.38-3.33 (2H,m,CH2CH=CH2), 2.78 (3H,s,4-
CH3), 2.48 (3H,s,I-CH3), MS(m/z) 235(M+, 100%), 220(55%)
CFound: C, 86.7? H, 7.5? N, 5.8. C|7 H^ N requires: C, 86.8? 
H, 7.3? N, 5.95%).
Rearrangement stud ies on 6-methoxv-l.4-dimethvl-9- 
(prop-2-eny 1) carbazol e 1 3 2 :
(I) with aluminum trichloride in dichloromethane. —  To an 
efficiently stirred solution of the dry carbazole 132 
(5.3 g, 20 mmol) in dry dichloromethane (250 cm^) at -30 C,
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a suspension of ( freshly ground aluminum trichloride 
(2.93 g, 22 mmol) in dry dichloromethane (10 cm3 ) was added 
in very small portions. The resultant mixture was then 
warmed to room temperature (20°C) gradually. After stirring 
for 7 h under nitrogen, the reaction mixture was quenched by 
being poured into a cold beaker of efficiently stirred water 
(250 cm^). Stirring was continued for 30 min. The aqueous 
layer was extracted with dichloromethane (2x 100 cm^). The
combined organic layers were washed with water <3x 150 cm^ ) , 
saturated brine (150 cm^), dried (MgSO^) and the solvent 
removed to yield a colourless solid. Column chromatography 
on silica gel, eluting with dichloromethane (30%) in 
petroleum ether, afforded three products in the sequence A, 
6 and C:
Product A, 6-methoxy-l.4-d imethvl-8-(prop-2-eny1)carbazole 
13-=* (3.28 g, 62%), m.p. 119-120°C, 1H n.m.r. 7.82 (1H,
br s,NH), 7.57 (lH,d,J=2.4 Hz,H-5>, 7.09 (lH,d,J=7.4 Hz, 
H-7), 6.91 (1H,d,J=2.4 Hz,H-2), 6.89 (lH,d,J=7.4 Hz,H-3),
6.12 (lH,m,CH=CH2> * 5.30-5.20 (2H,m,CH=CH2), 3.93 (3H,s,
OCH3), 3.70 (2H,d,J=6.2 Hz,CH2CH=CH2), 2.83 (3H,s,4-CH3>,
2.50 (3H,s,1-CH 3), MS(m/z) 265(M+, 100%), 250(60%), 224(10%)
CFound: C, . 81.7» H, 7.45; N, 5.2. C^.H^NO requires: C,
81.5; H, 7.2; N, 5.3%1.
Product B, 3-(2-ch1 oropropy1)-6-methoxy-l.4-dimethyl-
carbazo 1 e 15<£> (0.54 g, 9%), m.p. 120-121 °C, UV 234, 246,
255(sh), 265(sh), 295, IR(N) 3460, 1610, 1590, 1300,
1H n.m.r. 7.86 (lH,br s,NH), 7.60 (lH,d,J=2.4 Hz,H-5), 7.11
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( 1H, d ,J=7.3 Hz,H-2), 6.90 (lH,d,J=7.3 Hz,H-3), 6.89
(1H,d,J=2.4 Hz,H-7), 4.45 (1H,sextet,J=6.6 Hz.CHClCH^), 3.92 
(3H,s,OCH3), 3.42 (lH,dd,J=14.5, 6.6 Hz,CH(H)CHC1), 3.25 
(1H,dd,J=14.5, 6.6 Hz,CH(H)CHC1), 2.82 (3H,s,4-CH3), 2.54 
<3H,s,I-CH3), 1.59 (3H,d,J=6.6 Hz,C(H)CICH3), MS(m/z) 303
(19%), 301(M*, 57%), 265(100%), 250(58%), 238(40%) [Found:
C, 71.5; H, 6.6; N, 4.7. C|gH2QClN0 requires: C, 71.6; H,
6.9; N, 4.6%].
Product C, 6-methoxy-l.4-d imethy1-3-(prop-2-eny1)carbazole 
J L S S  (1.27 g, 24%), m.p. 125-126 °C, 1H n.m.r. 7.78
(1H,br s,NH), 7.75 (lH,d,J=2.6 Hz,H-5>, 7.36 (lH,d,J=8.8 Hz, 
H-8), 7.05 (1H,dd,J=8.8, 2.6 Hz,H-7), 7.02 (lH,s,H-2), 6.03
(lH,m,CH=CH2), 5.10-4.90 (2H,m,CH=CH2), 3.93 (3H,s,OCH3),
3.55 (2H,m,CH2CH=CH2), 2.77 (3H,s,4-CH3), 2.49 (3H,s,I-CH3), 
MS(m/z) 265(M*, 100%), 250(67%), 225(37%), 149(37%) CFound: 
C, 81.4; H, 7.4; N, 5.15. C^ g H-jg NO requires: C, 81.5; H,
7.2; N, 5.3%].
(II) with aluminum trichloride in nitromethane. —
Aluminum trichloride (80 mg, 0.6 mmol) in nitromethane 
(3 cm^) was added dropwise to a solution of the carbazole
•a o
132 (133 mg, 0.5 mmol) in nitromethane (7 cm-') at -10 C. 
After stirring at that temperature for 45 min, the resultant 
dark mixture was poured into water (50 cm^) and extracted 
with ethyl acetate (3x 30cm^). The combined organic layers 
were washed with saturated sodium hydrogen carbonate 
solution (30 cJ), water (2x 30 cm^), saturated brine
-104-
(30 cm^), dried < MgSO^), and the solvent removed to give a 
solid residue. Column chromatography on silica gel, eluting
(30%)
with dichloromethane^ in petroleum ether, afforded a 
colourless solid which was shown to be identical with
6-methoxy-l,4-dimethylcarbazole 138 (80 mg, 71%).
(III) with ethyl aluminum dichloride in dichloromethane. 
—  A solution of ethyl aluminum dichloride (1 M, 0.6 cm^ ) 
in hexane was added dropwise to a solution of the 
carbazole 132 (133 mg, 0.5 mmol) in dry dichloromethane
(15 cm^> at 0°C under nitrogen. The resultant mixture was 
stirred at room temperature for two days, however since tic 
analysis showed that starting material was still present, 
the reaction mixture was then heated to reflux for 4 h. Even 
after this treatment, no new products formed in any 
significant amount.
(IV) with boron trichloride in dichloromethane. —  A 
solution of boron trichloride (1 M, 0.6 cm^) in
dichloromethane was added dropwise to a solution of the
carbazole 132 (133 mg, 0'.5 mmol) in dry dichloromethane
(8 cm^) at -25°C under nitrogen. The reaction mixture was 
stirred for 11 h, but tic analysis of the reaction mixture 
on silica gel indicated only the presence of the starting 
carbazole. The mixture was then stirred at room temperature 
tor 20 h. Once more tic analysis revealed that some of the 
starting carbazole remained together with a significant
-105-
amount of black material at the baseline of the tlc-plate.
(V) with zinc(11) chloride in xylene. —  Zinc(II) chloride
(83 mg, 0.6 mmol) was added to a solution of carbazole 132 
(133 mg, 0.5 mmol) in dry xylene (10 cm^) at 0°C. The
resultant mixture was stirred at room temperature for 24 h 
before being heated under reflux for another 24 h. Tic 
analysis of the reaction mixture concluded that starting 
carbazole remained in majority together with some very minor 
components.
(VI) with trifluoroacetic acid in dioxane. —  A solution 
of carbazole 132 (133 mg, 0.5 mmol) in a mixture of
trifluoroacetic acid (0.5 cm^) and dioxane (5 cm^) was
stirred at room temperature for 24 h. Afterwards, tic 
analysis indicated mainly the presence of unreacted
carbazole.
Preparation of dimeric carbazoles 1 and 1 7 0 .
—  Powdered aluminum trichloride (640 mg, 4.8 mmol), was 
added to a solution of carbazole 132 (1.06 g, 4 mmol) in dry 
dichloromethane (50 cm^) at room temperature. After stirring 
tor 5 h under nitrogen, the resultant mixture was poured 
into cold water (100 cm^) and the aqueous layer was removed 
and extracted with dichloromethane (2x 50 cm^). The combined 
organic layers were washed with water (2x 50 cm^), brine
(50 cm^), dried (MgSO^) and the solvent removed to give a
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solid residue (890 mg). A fraction of the solid (100 mg) Has 
chromatographed on silica gel, eluting with dichloromethane 
(5% to 45%) in petroleum ether to afford, in order, the 
following two products:
Product (58 mg), m.p. decomp. 241-243 °C, UV 247,
258(sh), 268(sh), 299, IR(N> 3460, 1600, 1590, 1300,
n.m.r.(A, denotes proton resonances belonging to the 
8-unsubstituted carbazole unit and B, indicates protons 
resonances originating from the 8-substituted carbazole 
moiety.): 7.76 (A and B,2H,br s,2xNH, addition of dg-DMSO 
caused this signal to resolve into two broad singlets at 
10.08 and 9.44 ppm), 7.75 (A,1H,d,J=2.4 Hz,H-5), 7.62
(B,1H,d,J=2.4 Hz,H-5), 7.35 (A,1H,d,J-8.8 Hz,H-8), 7.27
(B,1H,s,H-2), 7.05 (A,1H,dd,J=8.8, 2.4 Hz,H-7), 6.99
(A,1H,s,H-2), 6.89 (B,1H,J=2.4 Hz,H-7), 6.11 (B,lH,m,
CH=CH2), 5.28-5.19 (B,2H,m,CH=CH2 ), 3.93 (A,3H,s,OCH3), 3.90 
(B,3H,s,OCH3), 3.69 (B,2H,m,CH2CH=CH2), 3.54 <lH,m,
C(H)CH3), 3.14 (lH,dd,J = 12.8, 5.3 Hz,C(H)HC(H)CH3) , 3.02
(lH,dd,J=12.8, 9.2 Hz,C(H)HC(H)CH3), 2.82 <B,3H,s, 4-CH3),
2.74 (A,3H,s,4-CH3), 2.55 (B,3H,s,1-CH3), 2.45 <A,3H,s,
I-CH3), 1.29 (3H,d,3—6.9 Hz,C(H)CH3), 13C n.m.r. 152.3,
152.1, 137.8, 137.3, 135.5, 134. 8, 134.5, 133.3, 128.3,
128.2, 127.0, 126.0, 123.8, 123. 6, 123.5, 121.9, 120.7,
120.5, 116.8, 115.9, 115.1, 112.3, 112.1, 110.3, 105.5,
103.4, 55.2, •O*r
inin 9, 35.0, 34. 8, 20.6, 16.4, 16.0, 15.4,
14.6, MS(m/z) 530(M+, 17%) , 380 (7%) , 307(3%), 292(100%),
238(24%) CFound: C, 81.3; H, 7.45; N, 5.0. C36H38N2O2
-107-
requires: C, 81.5; H, 7.2; N, 5.3%].
Product 137*0 (23 mg), m.p. decomp. 189-195°C, UV 247,
253(sh), 268(sh), 298, 1R(N) 3460, 1600, 1590, 1300,
n.m.r.(A, denotes proton resonances belonging to the 
8-unsubstituted carbazole unit and B, indicates protons 
resonances originating from the 8-substituted carbazole 
moiety.): 7.79 (A and B,2H,br s,2xNH>, 7.74 (A,1H,d,J=2.4
Hz,H-5), 7.64 (B,1H,d,J=2.2Hz, H-5), 7.33 (A,1H,d,J=S.6Hz, 
H-8 ), 7.29 (B,1H,s,H-2), 7.04 (A,lH,dd,J=8.6, 2.4 Hz,H-7),
7.00 (A,1H,s,H-2), 6.87 (B,1H,d,J=2.2 Hz,H-7), 4.45
(B,lH,m,C(Cl)HCH3), 3.93 (A,3H,s,OCH3), 3.90<B,3H,s,OCH3),
3.56 (1H,m,CH^C(H)CH3), 3.44 (B,1H,dd,J=15.4, 6.4 Hz,
CH(H)C(C1)H), 3.26 <B,1H,dd,J=15.4, 6.4 Hz, CH<H)C(Cl)H),
3.17 (1H,dd,J=13.6, 9.1 Hz,CH<H)CH(CH3)), 3.04 <lH,dd,
J=13.6, 5.4 Hz,CH(H)CH(CH3)), 2.82 <B,3H,s,4-CH3), 2.74
(A,3H,s,4-CH3), 2.59 <B,3H,s,I-CH3), 2.44 (A,3H,s,1-CH3),
1.57 (B,3H,2d,J=6.4 Hz,CH(Cl)CH3), 1.27 <3H,d,J=6.9 Hz,
CH<CH3)), MS(m/z) 568(3%), 566<M*, 10%), 530(17%), 328(58%),
292(97%), 238(60%) CFound: C, 76.1? H, 5.5; N, 4.7.
C36H 39CIN2O2 requires: C, 76.2; H, 5.2; N, 4.9%].
Dehvdrochlori nat ion of 8- (2-chlorooropy1)-6-methoxy- 
1. 4-d i met hv 1 carbazo 1 e JL5<£>. —  To a stirred solution of
the carbazole 156 <1.5 g, 5 mmol) in dry dimethylformamide 
(25 cm^) at 0°C, was added sodium hydride (0.44 g, 11 mmol, 
60% in oil dispersion). The resultant mixture was stirred 
under nitrogen at room temperature for 15 h and then poured
-108-
into a beaker of cold stirred water (75 cm^). The organic 
phase was separated and extracted with dichloromethane (2x 
80 cm^ ) . The combined organic layers were washed with water 
<3x 80 cm3), saturated brine (80cm^), dried (MgSC^ ) and the
4
solvent removed to give a solid residue. Column 
chromatography on silica gel, eluting with dichloromethane (30%) 
in petroleum ether, afforded a colourless solid (1.2 g, 91%) 
which was identical to 6-methoxy-l,4-dimethy1-8-(prop-2- 
enyl)-carbazole 134.
6-Methoxy-l. 4-d imethy 1 -8-prooeny 1 carbazol e 1 6 8 .
—  A solution of the carbazole 134 <4.5 g, 17 mmol) in dry 
benzene (100 cm^) and bisacetonitri1e pal 1 adium<11) chloride 
(0.5 g, 2 mmol) was stirred at 60 °C under nitrogen for 24 h. 
Benzene and the small amount of acetonitrile were evaporated 
off to give a dark residue which was subjected to column 
chromatography on silica gel, eluting with dichloromethane ( 30°/o) 
in petroleum ether. This afforded the title compound as a 
colourless solid (4.0 g, 89%), m.p. 138°C, UV 210(sh), 235,
283, IR(N) 3360, 1610, 1590, 1310, 1H n.m.r. 7.85
(1H,br s,NH), 7.56 <lH,d,J=2.4 Hz,5-H), 7.10 <lH,d,
3—7.1 Hz,2-H), 7.06 <lH,d,J=2.4 Hz,7-H), 6.88 <lH,d,J=7.14
Hz,3-H), 6.73 (1H,dd,J=15.6, 1.8 Hz,CH=CH<CH3)), 6.37
(1H, dq, J = 15. 6, 6.6 Hz, CH=CH (CH3 ) ) , 3.93 <3H,5,0^ 3), 2.81
(3H,s,4-CH3 ), 2.53 (3H,s,I-CH3), 2.02 <3H,dd,J=6.6, 1.8 Hz,
C(H)CH3 ), MS(m/z) 265(M+, 100%), 250(41%) (Found: C, 81.3?
H, 7.4; N, 5.2. Cjg H^ g NO requires: C, 81.5; H, 7.2; N,
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5.3%].
1. 4 -Pi met hv 1 -8-f or my I carbazo I e 1. 3^ S2 . —  Into a
stirred solution of propeny1carbazole 168 (5.31 g, 20 mmol)
in a dry mixture of methanol (100 cm^ ) and dichloromethane 
(100 cm^) at -20°C, was passed a stream of dry ozone gas, 
until no starting material remained (as indicated by tic 
analysis). A stream of dry nitrogen gas was then bubbled 
through the reaction mixture for 5 min to extrude excess 
ozone and then dimethyl sulphide (2 cm^) was added. After 
stirring at room temperature for 2 h, the solvent was 
removed from the resultant solution and column 
chromatography of the crude yellow residue on silica gel, 
eluting with ethyl acetate (10%) in petroleum ether then 
afforded the title compound as a yellow solid (4.0 g, 79%), 
m.p. 161°C, UV 230, 264, 298, IR(N) 3350, 1670, 1613, 1584,
1300, 1H n.m.r. 10.11 (lH,s,CH0), 9.88 (lH,br s,NH), 7.93
(lH,d,J=2.6 Hz,5-H), 7.36 (1H,d,J=2.6 Hz,7-H), 7.17 (lH,d,
3=7.3 Hz,2-H), 6.95 (lH,d,J=7.3 Hz,3-H), 3.97 (1H,s,0CH3),
2.80 (3H,s,4-CH3), 2.56 (3H,s,1-CH3 ), 13C n.m.r. 193.1,
153.0, 140.0, 133.6, 130.9, 127.2, 126.7, 121.6, 121.5,
118.5, 118.1, 115.6, 115.4, 56.5, 20.4, 16.6, MS(mTz)
253(M*, 100%), 238(97%) [Found: C, 75.9; H, 6.0; N, 5.4.
cl6 h 15N02 requires: C, 75.9; H, 6.0; N, 5.5%].
Trans-8-C 3-(d i ethv1 ami do)prop-2-env13-6-methoxy-1,4- 
d imethv I carbazole JL IP solution of diethyl
-110-
N,N-diethy1phosphonoacetamide 173 (5.75 g, 21 mmol) in dry 
dimethy1formamide (11 cm^) was added dropwise to a stirred 
suspension of sodium hydride (1.67 g, 41.7 mmol, 60% oil 
dispersion) in dry dimethy1formamide (160 cm^) at 15 t  under 
nitrogen. Stirring was continued for 10 min after the 
addition. The reaction mixture was then cooled to 0 t  as a 
solution of formylcarbazole 172 (4.36 g, 17.2 mmol) in dry 
dimethyIformamide (120 cm^) was introduced. The resultant 
red solution was stirred at room temperature for 24 h until 
all the formylcarbazole had reacted. The reaction mixture 
was poured into cold water (500 cm^) and extracted with 
ethyl acetate (4x 150 cm^). The combined organic layers were 
washed with water (4x 150 cm^), saturated brine (150 cm^), 
dried (MgSCfy) and the solvent removed to give a solid 
residue. Column chromatography on silica gel, eluting with 
ethyl acetate in petroleum ether, afforded the title 
compound as a yellow solid (5.91 g, 98%) m.p. 207°C, UV 238, 
255(sh), 315, 410, IR(N) 3250, 1630, 1610, 1590, 1200, 980,
1H n.m.r. 8.60 (lH,br s,NH), 8.21 (lH,d,J=15.2 Hz,
CH=CHC0NEt2>, 7.68 (lH,d,J=2.4 Hz,5-H>, 7.24 (lH,d,J=2.4 Hz,
7-H), 7.11 (1H,d,J=7.2 Hz,2-H>, 6.94 (lH,d,J=15.2 Hz,
CH=CHC0NEt2), 6.89 (1H,d,J=7.2 Hz,3-H), 3.95 (3H,s,OCH3>,
3.53 (4H,m,N(CH2CH3)2), 2.81 (3H,s,4-CH3), 2.52 (3H,s,
I-CH3), 1.30 (3H,t,J=7.1 Hz,NCH2CH3), 1.21 (3H,t,J=7.1 Hz,
NCH2.CH3), Ac c . MS (m/z) 350.197(M*, 65.9%, calc. 350.199),
277.111(100%), 262.039(31.31%) CFound: C, 75.3; H, 7.6; N,
7.9. C22 H26N202 requires: C, 75.4; H, 7.5; N, 8.0%1.
- I l l -
Trans-8-C 3- (diethyl am i do)prop-2-eny1]-3-formy1-6- 
met hoxy-1. 4-d imet hy 1 carbazo 1 e A © 3 ..— A dry 2-necked 
flask, fitted with a double surface water condenser was 
charged with a solution of imidazole <1.5 g, 22 mmol) in dry 
acetonitrile (120 cm^ ) . Freshly distilled trifluoroacetic 
anhydride <21.4 g, 102 mmol) was then added dropwise at room 
temperature. The mixture was bought to gentle reflux after 
the addition and while this reflux condition was maintained, 
a suspension of the carbazole 174 <5.91 g, 17 mmol) in dry 
acetonitrile (50 cm^) was added. After heating under reflux 
for a further 3.5 h under nitrogen, the resultant brown 
solution was cooled to room temperature. The solvent was 
removed and the residue was dissolved in a mixture of sodium 
hydroxide/ ethanol/ water <15 g/300 cm /150 cmJ) at room 
temperature and stirred at 80 °C for 15 min. Most of the 
solvent was then removed and the residue was treated with 
water (150 cm^ ) and extracted with ethyl acetate <4x 
100 cm^). The combined organic layers were washed with water 
<4x 80 cm^), saturated brine <80 cm^), dried (MgSO^) and the 
solvent removed. Column chromatography of the crude residue 
on silica gel, eluting with ethyl acetate in petroleum 
ether, afforded the pure title compound as yellow prisms 
<5.3 g, 83%), m.p. 230°C, UV 223, 253, 316, 380, IR<N) 3220, 
1670, 1640, 1580, 970, 1H n.m.r. 10.28 <lH,s,CH0), 9.58
(1H,s,NH), 8.25 <lH,d,J=15.4 Hz,CH=C<H)C0NEt2), 7.66 <lH,s,
2-H), 7.65 <lH,d,J=2.2 Hz,5-H), 7.19 <1H,d,J=2.2 Hz,7-H),
6.90 <1H,d,J=15.4 Hz,CH=C<H)CONEt2), 3.94 <3H,s,OCH3), 3.51
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(4H,q,J=7.1 Hz,N<CH2CH3)2), 3.07 (3H,s,4-CH3), 2.50 (3H,s,
l-CHj), 1.30 (3H,t,J=7.1 Hz,NCH2CH3), 1.18 (3H,t,J=7.1 Hz,
NCH2CH3>, 13C n.m.r. 191.5, 166.1, 154.1, 143.1, 136.9,
136.5, 134.4, 129.2, 126.4, 125.8, 121.8, 119.5, 118.8,
118.4, 110.1, 108.5, 56.2, 42.5, 41.3, 16.6, 15.1, 14.9,
13.2, MS(m/z) 378 (M* , 7%), 347(14%), 305(13%), 289(17%)
[Found: C, 73.1» H, 7.1; N, 7.4. C23H26 N2O3 requires: C,
73.01 H, 6.9; N, 7.4%3.
Formylation of 8-[3-(Diethyl ami do)propyl 3-1.4-d i- 
methyl -6-met hoxy carbazol e A JL . —  The same procedure as
described in the previous experiment was used with 
8-C3-(diethy1 amido)propyl 3-1,4-dimethyl-6-methoxycarbazo1e 
171 as substrate. Two products, A and B were obtained in the 
ratio 4:1 :
Product A, 8-C3-(Diethylamido)propyl 3-1,4-dimethyl-3-formyl-
6-methoxyCarbazole 180. Its n.m.r. spectroscopic data is 
the same as those given in the next experiment.
Product B, 8-C3-(Diethy1 amido)propy13-3,7-diformy1-1,4-di-
methyl-6-methoxycarbazole 181. n.m.r. 11.30 (lH,br s,NH), 
10.76 and 10.42(2H,2s,7-CHO and 3-CHO), 7.76 (lH,s, H-2),
7.68 (1H,s,H-5), 4.05 (3H,s,OCH3), 3.68 (2H,m,
CH2CH2CONEt2 ), 3.37 (2H,q,NCH2CH3), 3.22 (2H,q, NCH2CH3),
3.18 (3H,s,4-CH3), 2.92 (2H,m ,CH2CH2CONEt ), 2.67 (3H,s,
1-CH3), 1.02 (6H,t,2xNCH2CH3), MS(m/z) 408(M^).
8-C 3-(D i ethy1 ami do)propy13-1,4-d imethy1-3-formy1-6-
- 1 13 -
methoxycarbazol e I S O .  —  A solution of the carbazole 
183 (5.14 g, 13.6 mmol) in ethyl acetate (300 cm^) , in the 
presence of palladium (0.5 gf 10% w/w on activated carbon) 
was hydrogenated at atmospheric pressure and at room 
temperature until no starting material remained. The 
reaction mixture was filtered through a pad of celite to 
remove the catalyst. The filtrate was evaporated to give a
solid residue which after column chromatography on silica
(25%)
gel, eluting with ethyl acetateAin petroleum ether, afforded 
the title compound as a pale yellow solid (4.27 g, 82%), 
m.p. 162°C, UV 229, 251, 278, 297, 336, IR(S) 3230, 2920,
2850, 1730, 1660, 1620, 1030, 1H n.m.r. 10.68 (lH,br s,NH>,
10.42 (1H,s,CH0) , 7.71 (lH,s,2-H>, 7.63 (1H,d,J=2.6 Hz,5-H),
6.91 (1H,d,J=2.6 Hz,7-H), 3.94 (3H,s,OCH3>, 3.37 <4H,m,
NCH2'CH'3 and CH2CH2 CONEt^ > , 3.22 (2H, q, J=7. 3 Hz, NCH2CH3 ) ,
3.17 (3H, s, 4-CH'3) , 2.77 <2H,m, CH^CH^CONEt? ) , 2.62
(3H,s,I-CH3), 1.02 (6H,t,J=7.33 Hz,N(CH2CH3)2 ), Acc. MS(m/z) 
330.209(M+, 100%; calc. 380.210), 307.121(53.53%) [Found: C, 
72.8; H, 7.55; N, 7.3. C^-H^fcl^'O 3 requires: C, 72.6; H, 7.4; 
N, 7.4%3.
8-C3-(Piethv1 amido)propyl 3-1,4-dimethy1-6-methoxy- 
carbazole X X . —  The same procedure as described in
the previous experiment was used now at 60 psi, with 
8-C3-(diethylami do)propeny1D-6-methoxy-1,4-d imethy1carbazo1e 
174 (3.51 g, 10 mmol) as substrate. The title compound was 
thus obtained as a colourless solid (3.63 g, 97%),
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m .p. 120 °C, UV 235, 245, 255(sh), 294, IR<S) 3270, 1610,
1600, 1300, 820, 1H n.m.r. 9.84 (lH,br s,NH>, 7.54 (lH,d,
3=2.4 Hz,5-H), 7.07 (lH,d,J=7.3 Hz,2-H), 6.86 (lH,d,
J=2. 4 Hz,7-H), 6.84 <lH,d,J=7.3 Hz,3-H), 3.91 (3H, s, OCH.3) , 
3.34 (2H,m,CH2CH2‘CONEt2 ) , 3.33 <2H,q,J=7.1 Hz, NCH^CH^) , 3.14 
(2H,q,J=7.1 Hz,NCH2CH3), 2.82 (3H,s,4-CH3), 2.72 (2H,m,
CH2CHoCONEt^), 2.58 (3H,s,1-CH3), 1.00 <3H,t,J=7.I Hz,
NCH2CH3), 0.96 <3H, t, 3=7. 1 Hz,NCH2CH'3) , MS(m/z) 352 (M+ ,
100%), 306(10%), 279(78%), 264(12%) CFound: C, 74.8i H, 8.2; 
N, 7.9. c22M28'N2°2 re£lu*res: c» 75.0* H, 8.0* N, 7.95%3.
8-C 3-(Diethylami do)propyl 3-1,4-d imethyl-3-[N-(2,2- 
d i met boxy) ethyl ami nomethyl 3 -6-methoxycarbazole 1 8 5 .  —
A mixture of the formylcarbazole 180 (1.9 g, 5 mmol) and
excess dry aminoacetaldehyde dimethyl acetal (5.0 g), in the 
presence of activated molecular sieves (4A) was heated at 
80°C until all the formyl compound had reacted (as indicated 
by tic analysis on neutral alumina plates). Most of the 
remaining acetal reagent was removed under reduced pressure 
(0.05 mm Hg) at ambient temperature. The residue was 
dissolved in absolute ethanol (120 cm^) and was then 
hydrogenated, in the presence of platinum(IV) oxide (0.2 g), 
at atmospheric pressure and room temperature for 4 h. The 
hydrogenation mixture was filtered through a pad of celite 
to remove the catalyst and the filtrate evaporated to 
dryness to afford the title compound as a colourless solid 
(2.1 g, 90%). This was carried through without
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characterisation to the next stage.
8-C3-(Di ethyI ami do)propy13-1,4-d imethyl-3-CN-(2,2- 
d imethoxy)ethy1-N-tosy1-aminomethyI 3-6-methoxycarbazole 
1. Q  <£». —  To a stirred solution of the
aminomethy1carbazo1e 185 (2.1 g, 4.5 mmol) in dry pyridine 
(50 cm ) at 0 C, was added freshly recrystal 1ised tosyl 
chloride (1.02 g, 5.4 mmol). After stirring at room 
temperature for 24 h, the resultant brown solution was 
poured into water (200 cm^ ) and extracted with ethyl acetate 
(3x 80 cm^). The combined organic layers were washed
successively with hydrochloric acid (0.5 M, 3x 80 cm^), 
saturated sodium hydrogen carbonate solution (120 cm ), 
water (2x 80 cm^), saturated brine (80 cm^), dried (MgSO^) 
and the solvent removed. Column chromatography of the 
residue on silica gel, eluting with ethyl acetate in 
petroleum ether, afforded the title compound as colourless 
plates (2.38 g, 85%), m.p. 174°C, UV 238, 246(sh), 268, 297, 
IR(N) 3300, 1615, 1590, 1160, 1H n.m.r. 9.91 (lH,br s,NH),
7.75 (2H,d,J=8.3 Hz,Tosyl-Hs), 7.59 (lH,d,J=2.5 Hz,5-H),
7.30 (2H,d,J=8.3 Hz,Tosyl-Hs), 6.88 (lH,s,2-H), 6.87
(lH,d,J=2.5 Hz,7-H), 4,58 (2H,s,3-CH2N), 4.13 (lH,t,J=5.5
Hz , CH (OMe) £.) , 3.91 (3H, s, 6-OCH3) , 3.35 (2H,q,J=7.1 Hz,
NCH2CH.3) , 3.34 <2H,m,CH2CH2CONEt2 ) , 3.20 (2H,q,J=7.1 Hz,
NCH2CH3), 3.16 (2H,d,J=5.5 Hz,CH2CH(OMe)2), 3.12 (6H,s,
CH (0CH 3)2 ) , 2.81 (3H, s, 4-CH3 ) , 2.75 (2H,m, CH^Cf^ CONEt2.) ,
2.48 (3H,s,I-CH3), 2.42 (3H,s,SO^CfcH^C!^ ), 1.00 (6H,t,
- 1 1 6 -
2= 7.1 Hz,N(CH7CH3>2), MS(m/z) 623<M+ >, 366<100%), 293(77%),
278(20%), 250(20%) [Found: C, 65.3; H, 7.4; N, 6.7.
C34 requires: C, 65.5; H, 7.3; N, 6.7%].
7-13-(Diethyl ami do)propy13-9-methoxyel1ipticine 
1 8 7 .  —  Concentrated hydrochloric acid (10 M, 1.0 cm^ )
was added to a stirred solution of the carbazole 186 
(320 mg, 0.5 mmol) in dioxane <20 cm^> at room temperature 
under nitrogen. The mixture was stirred at 100°C for 3 h and 
then cooled to room temperature, diluted with water (40 cm^) 
and basified with concentrated ammonium hydroxide solution 
before being extracted with ethyl acetate (3x 40 cm^). The
combined organic layers were washed with water (2x 50 cm^l,
brine (50 cm^) and the solvent was removed to give a yellow 
residue. Column chromatography on silica gel, eluting with
(55%)
ethyl acetate ^  in petroleum ether, afforded the title 
compound as a yellow solid (116 mg, 56%), m.p. 163°C, UV 
210(30200), 243(26800), 296(62800), 337(6260), 410(4100),
IR(N) 3280, 1600, 1H n.m.r. 10.32 (lH,br s,NH), 9.68 (lH,s,
1-H), 8.45 (1H,d,J-6.2 Hz,3-H), 7.85 (1H,dd,J=6.2, 0.6 Hz,
4-H), 7.75 (1H,d,J=2.4 Hz,10-H), 6.97 (lH,d,J=2.4 Hz,8-H),
3.96 (3H,s,GCH}), 3.38 (2H,m, CH.2CH2 C0NEt2 > , 3.37 (2H,q,
J=7.14 Hz,NCH2CH3), 3.26 (3H,s,II-CH3)» 3*21 (2H,q,J=7.14
Hz ,NCH2CH3), 2.84 (3H,d,J=0.6 Hz,5-CH3), 2.79 (2H,m,
CH2CH2C0NEt3), 1.00 (6H,t,J=7.14 Hz,N(CH^CH3)2), Acc. MS
<m/z) 403.221(M+, 100%, calc. 403.226), 386(4.7%), 368(28%), 
353(3%), 348(8.1%), 330(50.7%) [Found: C, 74.6; H, 7.35; N,
- 117 -
10.4. C25H29N 302 requires: C, 74.4; H, 7.2? N, 10.4%3.
7-C3-(Pi ethyI aw i no)propyl3-9-methoxyeI1ipticine 
A 1 7 .  —  A solution of borane-methy 1 sulphide complex in
tetrahydrofuran <2 M, 0.55 cm3 ) was added dropwise to a dry 
solution of the ellipticine 187 (114 mg, 0.28 mmol) in
tetrahydrofuran (6 cm3 ) under nitrogen, heated under reflux. 
After 75 min, hydrochloric acid (6 M, 1 cm3) was added and 
the resultant solution heated for a further 15 min. It was 
then cooled to room temperature and the solvent removed to 
give a residue which was treated with water (20 cm^), 
basified with ammonium hydroxide solution and the solution 
extracted with ethyl acetate (3x 20 cm^). The combined
organic layers were washed with water (2x 15 cm^) and brine 
(20 cm^), and the solvent removed to give an oily residue. 
Column chromatography on silica gel, eluting with
triethy1 amine/ ethyl acetate/ petroleum ether (0.5:75:25), 
then afforded the title compound as an orange viscous oil 
(56 mg, 51%), UV 210(29860), 243(32030), 296(61840),
405(3980), IR(N) 3250, 1610, 1H n.m.r. 10.25 (lH,br s,NH),
9.59 (lH,s,l-H), 8.37 (lH,d,J=6.1 Hz,3-H), 7.72 (lH,d,
J=6.1 Hz,4-H), 7.64 (lH,d,J=2.4 Hz,10-H), 6.89 (lH,d,J=2.4
Hz,8-H), 3.88 (3H,s,OCH3), 3.15 (3H,s,11-CH3), 2.94 (2H,
br t, J=6. 7 Hz,CH2(CH2 )2 NEt.2-) , 2.68 (3H, s, 5-CH}) , 2.58
(4H,q,J=7.14 Hz,N(CH2CH3)2 ), 2.32 (2H,br t,J=6.7 Hz,
CH2NEt2), 1.93 (2H,m,CH.2CH2NEt2 ) , 0.94 (6H,t, J=*7. 14 Hz,
N(CH2CH3)2), 13C n.m.r. 154.1, 149.9, 142.2, 140.5, 137.8,
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133.1, 128.5, 125.1, 124.9, 124.6, 122.3, 115.9, 115.2,
103.4, 106.1, 56.2, 50.0, 46.3, 28.2, 23.0, 14.4, 12.3,
10.4, Acc. MS(m/z) 389.248(M*, 100%, calc. 389.246),
316.157(35.5%), 290.141(80.0%) [Found: C, 77.O', H, 8.2? N, 
10.7. C25H 31N3O requires: C, 77.1; H, 8.0; N, 10.8%3.
N.N-Diethyl chi oroacetami de JL i£>. —  Chloroacetyl
chloride (28.4 g, 250 mmol) at 0 °C was added dropwise to a 
vigorously stirred solution of diethylamine (36.5 g, 
500 mmol) in dry ether (75 cm^) at 0°C. The mixture was 
stirred overnight (15 h) at room temperature and then 
diluted with dichloromethane (150 cm^) and washed 
successively with hydrochloric acid (2 M, 80 cm^), saturated 
sodium hydrogen carbonate solution (80 cm^), water (2x
80 cm^) and brine (80 cm^). After drying (MgSO^), the
solvent was removed to give an oily residue, distillation of 
which afforded the title compound as a colourles oil
(25.4 g, 68%), b.p. 82 °C/0.1 mm Hg, IR(L) 1650, 1H n.m.r. 
(60 MHz) 4.10 (2H,s,C1CH2>, 3.40 (4H,q,J=7.1 Hz,
N(CH2CH3)2 ), 1,18 <6H,t,J=7.1 Hz,N(CH2CH3)2).
Diethyl N.N-di ethyl ami nocarbony1methylphosphonate
1 7 3  —  Triethyl phosphite (10.0 g, 60 mmol) and 
N,N-diethyl ch1oroacetamide 176 (7.5 g, 50 mmol) was stirred 
at 150°C for 2.5 h and the reaction mixture then distilled 
under reduced pressure to afford the title compound as a 
colourless oil (9.5 g, 75%), b.p. 166°C/0.04 mm Hg), IR(L)
-1 19-
1640, 1H n.m.r.(60 MHz) 4.21 (4H, m, (OCH^CH 3)2 ) , 3.45 <4H,m,
(NCH^C^^), 3.02 ( 2H, d , J=22 Hz,P(0)CH2), 1. 45-1. 00 < 12H, m ,
(OCH.2CH3)2 and N (CH2:CH 3)2 ) .
8-C3-(Di ethv1 ami do)propeny13-1,4-d imethy1-3-IN-(2,2- 
d imethoxy)ethylimi nomethy1i dene 3-6-methoxycarbazole 
i O Q .  —  A mixture of the formylcarbazole 183 (95 mg,
0.25 mmol) and excess dry aminoacetaldehyde dimethyl acetal 
(0.25 g), in the presence of activated molecular sieves (4A) 
was heated at 80°C until all the formyl compound had 
reacted, as indicated by tic analysis (on neutral alumina). 
The remaining acetal was removed under reduced pressure 
(0.05 mm Hg) at room temperature and the residue 
crystallised from benzene to yield the title compound as 
yellow prisms (69 mg, 73%), m.p. 181°C, UV 227(sh), 256,
315, 400, IR(S) 3320, 1640, 1610, 1590, 1130, 1H n.m.r. 8.83
(2H,br s,NH and CH=N), 8.21 (lH,d,J=15.2 Hz,CH=C(H)C0NEt2 )»
7.89 (1H,s,2-H), 7.75 (1H,d,J=2.2 Hz,5-H), 7.25
(lH,d,J=2.2 Hz,7-H), 6.94 (1H,d,J=15.2 Hz,CH=C(H)CONEt^),
4.74 (1H, t,J=5.6 Hz,CH(0Me)2 ), 3.96 (3H,s,0CH3), 3.84
(2H,dd, J=5.6, 1.1 Hz,NCH2CH(OMe)2 ) , 3.53 (4H,m, (NCH.2CH 3)2‘) ,
3.46 (6H, s,CH(0CH3)2 ), 2.95 (3H,s,4-CH3), 2.53
(3H,s,I-CH3), 1.31 (3H,t,J=7.15 Hz,NCH2CH3), 1.22
(3H,t,J=7.15 Hz, NCH2CH3), MS(mAz) 465(M*, 27%), 434(4%),
390(19%), 75(100%) C Found: C, 69.6i H,7.8; N, 8.95.
^27H 35N requires: C, 69.7; H,7.6; N, 9.0%1.
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8-C3-(Pi ethvI ami do)propenv13-1,4-d i met hy1-3-C N-(2,2- 
d imethoxy)ethy1 ami nomethv13-6-methoxycarbazole ± Q  *P . —
Sodium borohydride (12.5 mg, 0.33 mmol) was added to a 
solution of the Schiff*s base 188 (51 mg, 0.11 mmol) in
ethanol (10 cm^) at 5°C. The progress of the reaction was 
followed by studying the UV spectra of the reaction mixture 
at 20 min intervals and when no further changes was noted in 
the peak at max 314 nm, it was quenched by pouring the
reaction mixture into water (30 cm^ ) . The volume of this
mixture was reduced by about 50% and it was then extracted 
with ethyl acetate (2x 30 cm^). The combined organic layers 
were washed with water (2x 20 cm^), brine, dried (MgSO^) and 
the solvent removed to afford a yellow solid (46.5 mg, 91%) 
which was sufficiently pure for the next step. UV 244, 
260(sh), 402, IR(N) 3260, 1630, 1590, 1H n.m.r. 8.48
(1H,br s,NH), 8.19 (lH,d, J=15.2 Hz,CH=C(H)CONEt2>, 7.75
(lH,d,J=2.2 Hz,5-H), 7.24 (1H,d,J=2.2 Hz,7-H), 7.17
(1H,s,2-H), 6.95 (lH,d,J-15.2 Hz, CH“C(H)C0NEt2.)* 4.53
(lH,t,J=5.6 Hz , CH (OMe) 2 ) » 3.96 (5H, s,6-OCH3 and 3-CH2.NH) , 
3.52 (4H,m,N(CH2CH‘3)2v) , 3.37 (6H,s, CH(OCH3)2 ), 2.84
(2H,d,J=5.6 Hz,CH2CH(OMe)2 ), 2.82 (3H, s,4-CH3), 2.51
(3H,s, 1-CH3) , 1.90 (1H, br s,3-CH.2Nh), 1.30 (3H, t, J=7. 15 Hz ,
NCH2CH3), 1.21 (3H, t, J=7. 15 Hz,NCH.2CH3 ) .
8-C 3-(Diethvlamido)propenyl3-1,4-dimethyl-3-CN-(2,2- 
d imethoxy)ethyl-N-1osy1 ami nomethy13-6-methoxycarbazo1e 
i ^7O . —  Freshly recrysta11ised tosyl chloride (21.2 mg,
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0.11 mmol) was added to a stirred solution of the 
ami nomethy1carbazo1e 189 (40 mg, 0.086 mmol) in dry pyridine 
(10 cm^) at 0°C. After stirring at room temperature for 
24 h, the restultant brown solution was poured into water 
(40 cm^) and extracted with ethyl acetate (3x 20 cm^ ) . The
combined organic layers were washed successively with 
hydrochloric acid (0.5 M, 3x 20 cm^ ) , saturated sodium 
hydrogen carbonate solution (2x 20 cm^ ) , water (2x 20 cm^),
saturated brine (20 cm^), dried (MgSO^l and the solvent
removed to give a solid residue. Column chromatography of
(35 %)
which on silica gel, eluting with ethyl acetate^in petroleum 
ether, afforded the title compound as yellow prisms (49 mg, 
92%), UV 244, 261(sh), 317, 400, IR(N> 3300, 1640, 1590,
1320, 1150, 970, MS(m/z) 621(M+ ), 364, 291.
Attempted preparat i on of 7-13-(d iethyl ami do)propenvl3-
9-methoxvel1ioticine 1 JL . —  To a stirred solution of
the carbazole 190 (20 mg) in dioxane (4 cm^) at room
temperature under nitrogen was added concentrated 
hydrochloric acid (10 M, 0.1 cm^) was added. After stirring 
at 100 °C for 24 h, the mixture was cooled to room 
temperature, diluted with water (10 c J ) and basified with 
concentrated ammonium hydroxide solution. This mixture was 
extracted with ethyl acetate (3x 10 cm^) and the combined 
organic layers were washed with water (2x 10 cm^), saturated 
brine (10 cm^), dried (MgSO^) and the solvent removed. Tic 
analysis of the yellow residue which remained indicated the
-122-
presence of many components. n.m.r. analysis of the crude
residue, however, suggested there was no ellipticine like 
product had formed.
Catalvt i c reduct i on of 8-C3-<diethylaimdo)propenv13- 
1,4-d i methyl-3-T N-(2.2-d i methoxy)ethyl-N-tosyl-ami nomethyl 3 - 
6-met hoxyc arbazo 1 e JL*PO.—  A solution of the 
propenyIcarbazole 190 <20 mg) in ethyl acetate <20 cm^), in 
the presence of palladium <2 mg, 10% on activated carbon), 
was hydrogenated at atmospheric pressure and room 
temperature. The reaction mixture was filtered through a bed 
of celite to remove the catalyst and the filtrate was 
evaporated to dryness to give a colourless residue. Column 
chromatography on silica gel, eluting with ethyl acetate in 
petroleum ether, afforded a product which was identical with 
the propyIcarbazole 186 in all respects <19.6 mg, 98%).
C1ai sen rearrangement of 1.4-d imethyl-6- (proo-2-
enyloxy) carbazole 1 9 2  under thermal cond i t i ons. —  A 
solution of carbazole 192 <0.5 g, 2 mmol) in xylene <20 cm^) 
was heated to reflux for 60 h, then cooled and the solvent 
removed. Column chromatography of the residue on neutral 
alumina, eluting with dich1oromethane in petroleum ether, 
afforded 1.4-d imethy1-6-hydroxy-5-(prop-2-enyl)carbazo1e
A *iP S , a colourless solid <0.4 g, 80%), as the only 
product, UV 243, 250, 260<sh), 298, IR<N) 3420, 3380, 1600,
1210, 1170, n.m.r.(d^-Acetone) 10.12 <lH,br s,NH), 7.72
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(1H ,br s,OH), 7.29 (lH,d,J=8.4 Hz,8-H), 7.05 (lH,d,J=8.4
Hz,7-H), 7.02 (1H,d,3=7.3 Hz,2-H>, 6.81 (lH,d,J=7.3 Hz,
3-H), 6.20 (lH,m,CH=CH2), 5.05-4.25 (2H,m,CH=CH2>, 4.12
(2H,m,CH2CH=CH2), 2.93 <3H,s,4-CH3), 2-49 *3H,s,I-CH3).
C1ai sen rearrangement of 1.4-dimethyl-6-(prop-2- 
env 1 oxv) carbazole JL i_n the presence of boron
trich1oride. —  To a solution of carbazole 192 (1.29 g,
5 mmol) in dry dichloromethane (80 cm^) below -25°C, was 
added dropwise boron trichloride (1 M, 6 cm3) in dichloro- 
methane. After stirring at that temperature for 35 min, the 
mixture was poured into cold water (100 cm^) and the aqueous 
phase was collectedand extracted with dichloromethane (2x 
40 cm^). The combined organic layers were washed 
successively with saturated sodium hydrogen carbonate 
solution (50 cm^ ) , water (2x 50 cm^), brine (50 cm^), dried 
(MgSO^) and the solvent removed to give a solid residue. 
Column chromatography on flash silica, eluting with ethyl 
acetate (35%) in petroleum ether, afforded two products A 
and B:
Product A (0.15 g, 12%), was shown to be 1.4-d imethy1-6- 
hvdroxy-7- (prop-2-eny 1) carbazol e 1 9  6 , IR(S) 3440, 3300,
1610, 1300, 1H n.m.r. 7.78 (lH,s,NH), 7.61 (lH,s,5-H), 7.20
(1H,s,8-H), 7.08 (lH,d,J=7.3 Hz,2-H), 6.87 (1H,d,J=7.3 Hz,
3-H), 6.09 (1H,m ,CH=CH 2)» 5.18 (2H,m,CH=CH2), 4.87 (1H,
s,OH), 3.57 (2H,m,CH2CH=CH2), 2*78 <3H,s,4-CH3), 2.49 (3H,
s,1-CH3), 13 C n.m.r. 147.7, 139.4, 136.7, 134.6, 130.6,
-1 24-
125.9, 124.2, 123.7, 121.0, 120.4, 117.0, 116.4, 111.4,
108.8, 35.8, 20.3, 16.6.
Product B <1.07 g, 83%), was the major isomer and -found to 
be identical with 1,4-dimethy1-6-hydroxy-5-(prop-2-eny1) 
carbazole 195.
6-Methoxy-1,4-d imethy1-7-<prop-2-eny1)carbazo1e 
JL<£»S. —  A mixture of hydroxycarbazole 196 (251 mg,
1 mmol), benzyl triethyl ammonium bromide (687 mg, 2.5 mmol), 
methyl iodide (340 mg, 2.4 mmol), sodium hydroxide (100 mg,
2.5 mmol) in dichloromethane (30 cm^) and water <15 cm3) was 
stirred vigorously under nitrogen for six days. The mixture, 
was allowed to separate into two layers. The aqueous layer 
was collected and extracted with dichloromethane (2x 
50 cm3). The combined organic layers were then washed with 
water <2x 40 cm^), saturated brine (40 cm3 ), dried (MgSO^) 
and the solvent removed to give a solid residue. This after 
column chromatography on silica gel, eluting with
dichloromethane in petroleum ether, afforded the title
o
compound as colourless plates (236 mg, 89%), m.p. 110-111 C, 
UV 236, 243(sh), 254<sh), 265, IR(N) 3370, 1630, 1570, 1200,
1H n.m.r. 7.72 (lH,br s,NH), 7.59 (lH,s,5-H), 7.20 <lH,s,
8-H), 7.06 (1H,d,3=7.2 Hz,2-H>, 6.87 (lH,d,J=7.2 Hz,3-H),
6.09 <lH,m,CH=CH2>* 5.13-5.04 (2H,m,CH=CH2>» 3.93 (3H,
s,GCH3), 3.54 <2H,d, J=6.6 Hz,CH2CH=CH.2) , 2.82 (3H,s,4-CH3),
2.46 (3H,s,I-CH3), 13C n.m.r. 151.9, 137.4, 134.3, 130.2,
127.6, 125.6,123.0, 121.7, 120.4, 117.1, 115.4, 111.4,
-125-
104.3, 56.3, 34.9, 20.4, 16.5, M S (m/z) 265 (M*" , 100%),
250(25%), 235(27%) (Found: C, 81.5; H, 7.3; N, 5.2. C ^ H ^ N O  
requires: C, 81.5; H, 7.22; N, 5.3%].
3- (2-Methoxy-5-n itrophenvl ) prop-2-enoic acid 2 0 3  .
—  A mixture of 2-methoxy-5-nitrobenzaldehyde (18.1 g, 
100 mmol) and 1,3-propanedioic acid (15.6 g, 150 mmol) in 
pyridine (50 cm^ ) and piperidine (1 cm^) were heated at 
100°C for 4 h. The mixture was cooled to room temperature 
and poured into a stirred mixture of hydrochloric acid (6 M, 
70 cm^) and crushed ice (ca. 70 g). After 15 min of stirring 
in the aqueous acid, the solid which had precipitated was 
filtered off and washed successively with dilute 
hydrochloric acid (2 M, 20 cm^), cold water (3x 20 cm^).
Crystallisation from methanol afforded the title compound as 
colourless needles (18.7 g, 84%), m.p. 230°C, IR(N) 
3200-2600br, 1700, 1630, 1590, 1H n.m.r.(dfe-DMS0, a peak
corresponding to the resonance of the acidic proton was not 
observed in pure d^-DMSO, but was when in a mixture of 
d£-DMSO/CDCI3 : at 6.20 as a broad singlet) 8.35
(1H,d,J=2.7 Hz,6-H), 8.26 (1H,dd,J=8.5, 2.7 Hz,4-H), 7.75
(1H,d,J=16.5 Hz,CH=CHC02H), 7.30 (lH,d,J=8.5 Hz,3-H), 6.65
(lH,d, J = 16.5 Hz,CH=CHC02.H) , 4.00 (3H,s,OCH3>, MS(m/z)
223(M+, 36%), 193(90%), 192(100%).
3- (5-Ami no-2-met hoxypheny 1) prop-2-enoic ac i d 2  0  4 .
—  Mi trocinnamic acid 203 (1.0 g) in ethanol (20 cm^), in
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the presence of palladium (0.1 g, 10% on activated carbon) 
as catalyst was hydrogenated at atmospheric pressure and 
room temperature for 4 h. The reaction mixture was filtered 
through a bed of celite to remove the catalyst. The filtrate 
was evaporated to dryness to leave a crystalline residue 
which was recrystal 1ised from ethanol to give the title 
compound as colourless plates (0.92 g, 91%), m.p. decomp. 
276°C, IR(N) 2800-2400br, 1620, 1590, 1500, 1H n.m.r.
(d -DMS0) 6.80-6.30 (3H,m,Ar-Hs), 6.5-5.1(3H,very br s,NH3>,
3.74 (3H, s, OCH3 ) , 2.60 (4H, m, CH.^CH^CC^' > , MS<m/z) 195(M+ ,
100%), 180(10%), 162(22%), 134(60%).
Diethyl 3-(2-methoxy-5-ni trophenvl)prop-2-enami de
2 0 5 .  —  Ni troc i nnamic acid 203 (22.3 g, 100 mmol) in
thionyl chloride (80 cm^) was heated to reflux under a dry 
atmosphere for 3 h. Excess thionyl chloride was removed and 
the residue was dissolved in dry benzene (200 cm^) and 
cooled to -10°C. Then freshly distilled triethylamine 
(26 cm^, 250 mmol) was added dropwise. Stirring was
continued while the reaction mixture was held at 0 C for 
30 min before the temperature was raised to 60°C for 3 h. 
After removing the solvent, the residue was taken up in 
dichloromethane (200 cm^) and washed successively with 
diluted hydrochloric acid (2 M, 100 cm^), saturated sodium 
carbonate (100 cm^), water (2x 100 cm^  ), saturated brine
(100 cm^). After being dried (MgSG^), the solvent was 
removed to yield a solid residue which crystallised from
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ethyl acetate in petroleum ether, as colourless prisms 
(23 g, 83%), m.p. 100-101 °C, UV 275, 304<sh), IR(N) 1630,
1600, 1570, 1330, 1270, 1260, 1H n.m.r. 3.39
(1H,d,J=2.8 Hz,6-H), 3.22 (1H,dd,J=9.0, 2.8 Hz,4-H), 7.96
<lH,d,J=15.6 Hz,CH=CHC0NEt2>, 6.99 (lH,d,J=9.0 Hz,3-H), 6.98 
(1H, d , J = 15. 6 Hz,CH=CHCONEt 2) , 3.99 < 3H, sf OCH'3) , 3.51
(4H,m,N(CH2CH3)2 ), 1.25 <6H,m,N (CH2CH3 >2 )» MS(m/z) 278(20%),
247(37%), 206(100%), 190(39%).
Pi ethyl 3-(5-ami no-2-methoxvpheny1)prop ionami de
20«£». —  A solution of the unsaturated nitroamide 205
(20 g) in ethyl acetate (200 cm^), in the presence of 
palladium (2 g, 10% on activated carbon) as catalyst was 
hydrogenated at atmospheric pressure, in the dark. The 
solution was filtered through a bed of celite to removed the 
catalyst and the filtrate was evaporated to dryness to 
afford an amber oil (17.6 g, 98%), IR(L) 3450, 3300, 3250,
3000, 1760, 1620, 1H n.m.r. 6.70-6.50 (3H,m,Ar-Hs), 3.78
(3H,s,0CH3), 3.62 (2H,s,NH2>, 3.47 (4H,m,N(CH2CH3)2 ), 2.81
(4H,m,CH2CH2CONEt2), 1.20 (6H,m,N(CH2CH3)2), MS(m/z) 250(M^,
100%), 223(15%), 219(20%), 72(21%)
Diethyl 3-(2-methoxy-5-methy1su1 phony1 ami nooheny1)-
prop i onam i de 2 O . —  Dry pyridine (30 cm^) was added
dropwise to a solution of amide 206 (12 g, 48 mmol) in dry 
dichloromethane (120 cm^) at 0°C. This was followed by the 
introduction of methy1su1 phony 1 chloride (7.15 g,
- 128 -
62.4 mmol). The reaction mixture was stirred at room 
temperature for 24 h and then poured into water (100 cm^ ) . 
The aqueous phase extracted with dichloromethane (2x 60 cm^ ) 
and the combined organic layers were washed successively 
with diluted hydrochloric acid (2 M, 80 cm^), saturated 
sodium hydrogen carbonate (80 cm^), water (2x 80 cm^),
saturated brine (100 cm^), dried (MgSO^) and evaporated. The 
residue was crystallised from ethyl acetate in petroleum 
ether, to afford the title compound as a colourless solid 
(12.9 g, 82%), m.p. 166°C, UV 234, 283, IR(S) 3280, 1630,
1330, 1150, 1H n.m.r. 8.81 (lH,br s,NH>, 7.15 (1H,dd,J=8 .6 ,
2.7 Hz,6-H), 7.11 (1H,d,J=2.7 Hz,2-H>, 6.80 (lH,d,J=8.6 Hz,
5-H), 3.81 (3H,s,OCH3), 3.34 (4H,m,N(CH2CH3^ >, 2.90 (2H,
m,CH2CH2CONEt2), 2.89 (3H,s,S02CH3), 2.55 (2H,m,
CH2CH2CONEt2), 1.12 <6H,m,N(CH2CH3)2 >, MS(m/z) 328(M*, 97%), 
297(11%), 249(90%), 222(6%), 100(100%) [Found: C, 54.7?
H, 7.55» N, 8.4. C15 H ^ N ^ S  requires: C, 54.9; H,7.4? N,
8.5%3.
Pi ethv1 3-[5-(2.2-di ethoxvethy1)methylsu1 phony1 ami no-
2-methoxypheny 1 3-propionamide 2 0  JL . —  A solution of the
sulphonamide 207 (3.28 g, 100 mmol) in dry dimethy1formamide 
(25 cm^) was added dropwise to a stirred suspension of 
sodium hydride (0.43 g, 60% in oil dispersion) in dry 
dimethy1formamide (10 cm^) at room temperature under 
nitrogen. The solution was stirred at room temperature for 
15 min and then cooled to 0 °C. A solution of
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2-bromo-1,1-diethoxyethane (23.6 g, 120 mmol) in dry
dimethy1formamide (5 cm^ ) was then added. The resultant 
mixture was stirred at room temperature for 15 min and then
o
at 100 C for 4 h. It was allowed to cool, poured into water 
(250 cm^) and extracted with ethyl acetate (3x 100 cm^). The
combined organic extract was washed with water (3x 100 c m ,
saturated brine <100 cm^l, dried (MgSO^) and the solvent 
removed to yield a solid residue. Column chromatography of 
which on silica gel, eluting with ethyl acetate <65%) in 
petroleum ether, afforded the title compound as a colourless 
oil <3.37 g, 76%), IR(L) 3000, 2800, 1640, 1510, 1350,
1H n.m.r. 7.42-6.85 <3H,m,Ar-Hs), 4.66 <lH,t,J=6.2 Hz,
CH(0Et)2), 3.86 <3H,s,OCH3), 3.61 <4H,ro,0 <CH2CH3 )2 ), 3.34
<4H,m,N<CH2CH3)2 ) » 3.30 <2H, d , J=6. 2 Hz , CH2.CH <0Et )2 ) ,
3. 08 (3H, s, S0.2CH3) , 2.97 <2H,m,CH2CH2CONEt 2) , 2.68 <2H,m,
CH2CH2CONEt2 ) , 1.10 <12H,m,N<CH2CH3)2 and CH <0CH.2 CH})2 ) ,
MS(chemi cal ionization) 445<M+ + 1, 6.3%), 399<100%),
353 <97%), 329 <32%), 291<19%).
Diethyl 3-< 5-methoxy-1-methy1su1 phony 1indolyl)pro-
p i onami de 2 0 8  . —  A solution of distilled titanium
tetrachloride <0.12 cm^, 1.1 mmol) in dry toluene (3 cm^)
was added dropwise to a solution of diethyl acetal 201
7 > 0(0.44 g, 1 mmol) in toluene <12 cm ) at 110 C under 
nitrogen. Throughout the addition which lasted 3 min, the 
reaction mixture was maintained under reflux and was heated 
for a further 20 min afterwards. When cooled, the resultant
-130-
mixture was poured into cold saturated sodium hydrogen 
carbonate solution <40 cm^ ) . The aqueous layer was then 
extracted with ethyl acetate (2x 25 cm^) and the combined 
organic layers were washed with water (2x 20 cm^), saturated 
brine <20 cm^), dried (MgSO^), and the solvent removed to 
yield a solid residue. Column chromatography of the residue 
on silica gel, eluting with ethyl acetate in petroleum 
ether, gave the title compound as a colourless solid (31 mg, 
9%), m.p.127*0, UV 223, 257, 263(sh>, IR(S) 2940, 1620,
1460, 1370, 1150, 1H n.m.r. 7.72 <lH,s,7 - H ) ,  7.74 (lH,d,
J=3.7 Hz,2-H), 7.02 (lH,s,4-H), 6.63 (lH,d,J=3.7 Hz,3-H),
3.88 <3H,s,OCH3), 3.39 <2H,q,J=7.1 Hz, NCfc^ CH.3) , 3.31
<2H,q,J=7.1 Hz,NCH2CH’3 ) , 3.08 (2H, m, CH2CH^)NEt 2 ) , 3.07 (3H,
s, SO2CH3) , 2.61 (2H, m, CH^CH^CONEt^ ) , 1.15 <3H,t,J=7.1 Hz,
NCH2CH3), 1.12 <3H,t,J“7.1 Hz,NCH-2CH3) , MSdn/z) 352 <M+ ,
30%), 321(3%), 279(1%), 273(3%), 251(22%), 141(100%) [Found: 
C, 57.9? H, 7.0; N, 7.8. C17 H.2^  N2.0 4S requires: C, 57.9;
H,6.9; N, 7.95%3.
-  131 -
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